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Abbreviation Definition
AUDIT World Health Organization alcohol use disorders identification test
BMI Body mass index
EQ-5D-3L Three-level version of  the EuroQol group’s health-related quality of  life measure
EQ-5D-5L Five-level version of  the EuroQol group’s health-related quality of  life measure
HADS Hospital anxiety and depression scale
HHS Harris hip score
HJR Harris Joint Registry
HRQoL Health-related quality of  life
ICD-10 International Classification of  Diseases 10th revision
JSW Joint space width
MGH Massachusetts General Hospital
MID Minimal important difference
OA Osteoarthritis
PRO Patient-reported outcomes
PROM Patient-reported outcome measure
SHAR Swedish Hip Arthroplasty Register
THR Total hip replacement
UCLA activity University of  California Los Angeles activity score survey
VAS Visual analogue scale
Abbreviations
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Background
Total hip replacement (THR) is a successful treatment 
for end-stage hip osteoarthritis (OA). Patients com-
monly seek this treatment to improve physical function, 
diminish pain, and ultimately to increase health- related 
quality of  life (HRQoL). In recent years, patients have 
been asked to self-assess these areas using patient- 
reported outcomes measures (PROMs) both before 
and after treatment. Combining PROMS with national 
registers allows identification of  factors that may influ-
ence how a patient will do after treatment. Detection of  
factors influencing poor outcomes after elective THR is 
important for understanding how to improve the effec-
tiveness of  this treatment.
Objectives
These works aimed to identify patient factors that con-
tribute to better or worse patient-reported outcomes 
(PROs) after THR and to identify the most influential 
patient factors on surgical recommendation. In doing 
so, new PROMs were explored, as were various metho-
dologies for investigating these types of  data.
Patients and Methods
The first four papers utilized patients from the national 
Swedish Hip Arthroplasty Register (SHAR) while the 
last two papers include patients from the Harris Joint 
Registry (HJR). The influence of  comorbid conditions, 
education, marital status, mental health, OA severity, 
and preoperative health states on surgical recommen-
Abstract
dations and patient-reported HRQoL, pain, and satis-
faction after THR was explored. A new version of  the 
EQ-5D survey was investigated as was how best to treat 
the relationship between the preoperative and post-
opera tive EQ-5D index scores.
Results
On average, PROs improved after THR. Those who 
started with worse scores tended to improve similar 
amounts to those with better preoperative scores; how-
ever, due to their starting point, they did not achieve 
scores that were as high after surgery. Individuals with 
greater musculoskeletal comorbidities, with low or me-
dium levels of  education, and a history of  preoperative 
antidepressant use, were identified as being patients who 
began and ended with worse PROs. The patient’s joint 
space width had the greatest influence on THR recom­
mendations. The new version of  the EQ-5D survey ap-
peared to better measure HRQoL in both preoperative 
and postoperative patients. Less ceiling effects were seen 
and substantial utilization of  the new answer options 
occurred particularly before THR surgery.
Conclusions
Patients at risk for poor outcomes can be identified 
through preoperative reporting of  musculoskeletal co-
morbidities and their medical record. Clinicians are not 
discouraged from treating these patients, but rather are 
encouraged to discuss individual risk factors to aid in the 
decision-making process for the patient.
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Total Hip Replacement
Osteoarthritis (OA) is a joint disease common in aging 
individuals.78 In a Swedish population, hip OA ranged 
from less than 1% in patients younger than 55 and up to 
10% in those over 85.19 Because symptomatic OA results 
in chronic pain and functional disability, patients experi-
ence diminished health-related quality of  life (HRQoL). 
If  these symptoms persist despite non-surgical interven-
tions like physical therapy and pain medication, total hip 
replacement (THR) is commonly recommended. THR 
is a highly effective treatment for patients suffering from 
end-stage OA of  the hip.78 Components are placed in 
the femur and the acetabulum of  the pelvis as a means 
to replace the articulating ball-and-socket hip joint. The 
success of  THR has been so great that it was named 
‘the operation of  the century’.61 This clinician- assessed 
surgical success however was traditionally based upon 
implant material and design performance assessed via 
radiographic analysis by surgeons and through sur-
geon-assessed functional status or survivorship of  the 
implanted components. Survivorship or success was de-
fined as an implant system remaining in a patient with 
no revision or exchange of  components, rather than 
improvement in the patient’s pain or functional status. 
While development of  new implants continues, data 
suggest that many hip implants consistently have greater 
than 95% survivorship at 10 years.29 Despite technical 
surgical success, a proportion of  patients have persistent 
pain, diminished physical function, and/or dissatis-
faction after ‘the operation of  the century’.2,15,67,69 
Hip OA is a painful debilitating condition, but it is not 
life threatening. Treatment of  OA with THR is common 
and safe, but like any surgical procedure, not without 
risks (e.g. the risk of  fatal pulmonary embolism after 
THR ranges from 0.2% to 5%32). Because THR is most 
commonly elective and intended to improve HRQoL not 
to prevent death, the patient’s functional improvement 
and satisfaction need also to define successful THR 
rather than just the implant survivorship. A promising 
way to improve upon 95% survivorship of  a particular 
implant system is to shift focus to patient-reported out-
comes (PROs) such as HRQoL, pain, and satisfaction. 
The patient may not be enthusiastic about an implant 
remaining in their hip for ten years if  they are living with 
constant pain and inhibited function. Patient-reported 
outcome measures (PROMs) allow the patient’s voice 
Background and Introduction
to be heard and become a part of  the treatment pro-
cess. Inclusion of  PRO in assessing THR will allow for 
further improvement in this surgical treatment perhaps 
making it also the operation of  the twenty­first century. 
Patient-Reported Outcomes
A PRO is any account of  a person’s health status re-
ported directly by the individual without interpretation 
by another person. While the term can be misleading, 
PROs are not limited to outcomes after an interven-
tion, but rather can be reported at any point in time and 
represent the individual’s personal assessment of  their 
feelings or functional ability with respect to their health 
at that moment. Patient- reported outcome measures 
(PROMs) are the standardized instruments designed 
to measure specific elements, known as constructs and 
domains, of  a person’s health status. PROs are assessed 
using PROMs as a means to standardize the evaluation 
of  a particular area of  health, condition, or treatment 
rather than using qualitative inter views. The FDA en-
courages measurement of  PROs for clinical trials that 
assess new medical devices and products because the 
patient’s perspective is a critical piece of  determining 
medical treatment efficacy.80 
General versus Specific Measures
Common areas measured with PROMs in THR patients 
are HRQoL, general health and wellbeing and symp-
toms such as pain, functional impairment, stiffness, and 
activity. PROMs can be printed on paper or adminis-
tered through electronic systems where the patient in-
puts their responses directly into a computer-generated 
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survey. Patients complete surveys in the clinical office or 
at home via mailed forms or through a secure emailed 
internet hyperlink.84
PROs are measured using two types of  PROMs: gene-
ral and specific health measures. Both types of  PROMs 
share valuable information about a patient’s health 
 status, but each provides a different look at the patient’s 
condition. General health measures broadly assess health 
across subpopulations, medical conditions, or treatment 
groups. While general health measures do provide in-
formation on the individual level, they typically are in-
tended to provide a more global look at health and allow 
comparisons between populations or treatment groups 
thus providing greater generalizability. Broad continued 
use of  general measures adds to the cumulative knowl-
edge of  health and quality of  life outcomes and can 
establish the relative burden of  different diseases and 
the relative merit of  different interventions.74 Treatment 
policy or resource allocation decision makers tend to be 
more interested in differences between subjects rather 
than within-person changes of  a particular treatment 
type; making general health measures particularly im-
portant for setting healthcare standards. 
Specific measures, alternatively, are designed to target 
defined diagnostic groups, particular populations, body 
parts, or organ systems. They are typically utilized to ob-
serve changes in or responsiveness of  a particular con-
dition to a treatment on the individual patient level. Spe-
cific measures are most commonly administered at two 
or more time intervals to determine the within-patient 
change. Investigators implementing specific measures 
typically tailor the survey to the intervention of  inter-
est to understand specific patient concerns and identify 
small clinically important changes after treatment.74 If  
well designed, specific measures provide a high level of  
specificity, but as a trade­off, have low generalizability 
outside the targeted population. To mitigate this, many 
studies which implement PROMs utilize both general 
and specific measures.
PRO Collection Challenges
Implementation of  PROMs in any medical practice re-
quires additional effort from the medical office staff  and 
the patient. An organized system for distribution, collec-
tion, and retention of  patient-reported surveys is critical 
to make proper use of  the data. In order to enhance the 
rate of  patient compliance, the questionnaire needs to be 
as brief  as possible, while also providing enough valuable 
information to justify the collection effort. An extensive 
questionnaire consisting of  multiple general health mea-
sures as well as several disease­specific surveys may pro-
vide a broad profile of  the patient’s health, but result in 
low levels of  compliance due to the burden on the patient. 
When collecting PRO data on the national level, a short 
survey is critical to maintain high levels of  patient compli-
ance because all patients receiving THR are asked to par-
ticipate. Numerous survey questions may be a deterrent 
for some patients resulting in low rates of  compliance 
and diminished generalizability for national register-based 
observational studies. Cohort studies and clinical trials on 
the other hand, have a bit more leeway with the number 
of  questions a patient can be asked. Participants in target-
ed prospective studies provide informed consent agreeing 
to complete the collection of  selected survey questions. 
Therefore, the patient has an understanding of  the time 
and effort necessary and consents to participation.
When selecting PROMs, it is also important to choose 
surveys which have been validated and their reliability 
tested to ensure that the questionnaire items are uni-
versally understood and measuring the same construct 
across all patients. Without validation and input from 
patients on their interpretation of  survey questions, the 
investigator may believe they are collecting different in-
formation than the patient is providing (Table 1).
Table 1.  Summary of Acceptability Criteria for a Validated PROM97
Validity Content validation* How well the content of survey items meets the criteria of experts
Criterion validation How well a scale correlates to the ‘gold-standard’ measurement of the area of interest
Construct validation How well a relationship between behaviors or attitudes is explained
Reliability Repeatability How reproducible the scale’s results are under different conditions
Internal consistency How well items within the same domain correlate to one another
Responsiveness* How well a scale can measure meaningful change in a clinical state63
*Not all survey development theorists find this necessary.97
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Patient-reported experience measures (PREMs) are im-
portant when clinics aim to assess or improve the patient 
experience within the healthcare setting. However, when 
asking a patient about satisfaction with their outcomes 
after treatment, the investigator wants to ensure the pa-
tient provides this rather than receiving satisfaction with 
the experience at the clinic. These subtle differences be-
tween PREMs and PROMs can influence results, thus 
confirmation of  face validity of  survey items is essential 
to confirm measurement of  the area of  interest.
Ideal intervals for questionnaire administration must 
also be established. Depending upon what information 
the clinician is interested in collecting, the questionnaire 
may need to be administered more or less frequently. 
One clinician maybe interested in health status imme-
diately following a procedure while others may be more 
interested in how the patient is doing after the average 
recovery period. Similarly, different treatments are in-
tended to provide relief  from symptoms for varying 
amounts of  time. Clinics interested in understanding 
how well an intervention has worked will need to ad-
minister their questionnaire both before and after the 
treatment. In order to understand how well a particular 
intervention is working, surveying patients at consistent 
intervals may provide a clearer picture of  how the treat-
ment influences changes over time.
PRO Interpretation Challenges 
Interpretation of  the patient-reported data can be chal-
lenging. Because there are many different health mea-
sures commonly found in the literature for THR pa-
tients, generalizability and direct comparisons between 
centers, regions, or nations can be limited. Even when 
the same instrument is used, scoring may vary between 
populations. The EQ-5D index is a weighted measure of  
HRQoL based upon responses to the five dimensions 
of  the instrument. Several national value sets specific 
to their cultural norms exist based on time-trade-off  or 
visual analogue scale (VAS) studies conducted on that 
country’s general population. Because of  cultural differ-
ences, populations may value one area of  health higher 
than another. To account for these differences, nation-
al value sets weight the patient’s responses differently. 
Therefore, comparisons of  EQ-5D indices across na-
tions cannot be done in a one-to-one fashion; trends may 
need to be considered rather than absolute index values.
There are two conflicting concerns about patient re-
sponse trends that could influence the sensitivity or re-
liability of  a PROM. First, end-aversion bias suggests 
that respondents are reluctant to select answers in the 
extremes because individuals do not want to make abso-
lute judgments like ‘always/never’ or ‘best/worst’.97 In 
some cultures where individualism is not encouraged, 
responses in the extremes may be rare, ultimately causing 
one population to appear very different from  another. 
Alternatively, ceiling and floor effects occur when the 
respondents answer predominantly in the extreme. 
 Responses of  this sort do not allow room to measure 
improvement or degradation over time or after treat-
ment. Ceiling and floor effects also make it very difficult 
to distinguish between those who see good improve-
ment versus those who see very good improvement and 
vice versa. Any continuous scale with end-points, such 
as a VAS or index, has the capacity to have ceiling and 
floor effects. The goal of  an instrument though should 
be to provide enough levels between those end-points to 
minimize floor and ceiling effects. An overwhelming use 
of  either response trend, end­aversion or floor/ ceiling 
effects, may suggest the instrument is not sensitive or re-
liable to measure the area of  interest in that population. 
A common question, which arises with the presentation 
of  PRO data, is whether changes measured correspond 
to clinically relevant improvement or degradation. Un-
fortunately, this is sometimes not a straightforward 
question to answer. Clinicians and policy makers are 
inte rested in the minimal important difference (MID) 
provided by a particular treatment as a means to assess 
efficacy or differences between groups. Several meth-
odologies exist to calculate MIDs however these calcu-
lations differ greatly, the patient’s opinion is not always 
included, and consensus of  which to used does not 
exist.57 When measuring subjective domains such as 
HRQoL or pain, assessment must come from the indi-
vidual rather than dictated by the clinician. The signifi-
cance of  a MID is dependent upon the population used 
to calculate the value. MIDs calculated from individual 
responses may not translate to changes measured on 
the population level. For example, if  a MID were es-
tablished at the patient level and the average change for 
a population is below that MID value, then the distri-
bution of  change is more important than the average. 
A narrow distribution of  change likely indicates that the 
treatment may not have been effective, but if  the distri-
bution of  change was broad, it is likely that the treat-
ment was productive or deleterious for some portion of  
the popu lation.12 Universal MID values for PROMs are 
theo retically appealing, but without a strong understand-
ing of  the implications of  the MID on the patient versus 
the population level, they can be misleading. Some may 
argue that small changes on the population level are not 
clinically relevant, thereby dismissing a particular PROM 
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as unimportant. However, upon closer inspection, sub-
groups within the larger population may ultimately show 
highly significant differences in the benefit or lack of  
improvement from a particular treatment. 
Swedish Hip Arthroplasty Register
The national Swedish Hip Arthroplasty Register (SHAR) 
is a prospective THR data repository that collects level I, 
II, and III data (Table 2).
The aim of  the SHAR is to capture all THR cases na-
tionally with the purpose of  describing the epidemiology 
and the clinical outcomes of  THR in Sweden and to effi­
ciently identify any problems associated with the proce-
dure. Complete prospective, national collection of  sur-
gical, component, follow-up, and patient-reported data 
provides an indispensable tool for clinical care. By fol-
lowing the national THR population over time both be-
fore and at regular intervals after treatment, the register 
is able to attain statistical power which is not possible in 
a single hospital or randomized trial. Rare complications 
associated with surgical techniques or implants are iden-
tified more quickly due to the huge  sample size from the 
national register. The SHAR is one of  the 12 full mem-
ber registers of  the International Society of  Arthroplasty 
Registers (ISAR). Full ISAR membership requires over 
80% compliance of  national hospitals (coverage) and 
that those reporting provide a minimum completeness 
of  90% of  the total joint replacement procedures from 
each medical unit.48 In 2011, the SHAR reported 100% 
coverage with all hospitals conducting THR reporting to 
the register with 98% of  all THRs reported.29 
Benefits of National Prospective Observational  
(Register) Studies
Register studies remove biases common in epidemiologi-
cal studies. Selection bias is mitigated by the complete col-
lection of  the THR patient population within the country 
(‘completeness’). Information or recall bias is minimized 
due to the prospective nature of  the surgical and pa-
tient-reported data collection. While data entry errors 
may occur, these are minimal.29 Finally, because health is 
all encompassing, not all health-related confounders may 
be collected within the SHAR. Linkage studies, which 
merge additional interdisciplinary official national regis-
ters with the SHAR, provide additional risk factors and 
confounders for exploration allowing deeper understand-
ing of  outcomes after THR treatment.
The ability to conduct comprehensive post-market sur-
veillance is greatly enhanced by registers. Development 
Table 2.  Patient- and Procedure-related Data Classified by Levels of Registry Data
Data Type Level I Data Level II Data Level III Data Level IV Data
Patient-related 
Personal ID
Sex
Diagnosis
Ethnicity°
Death
ASA score+
Height
Weight
Surgeon-defined Charnley Class°
PROMs
Sick leave*
Functional recovery*
Procedure-related
Date of surgery
Type of procedure
Laterality
Hospital ID
Surgeon ID°
Reoperation and/or revision
Prophylactic measures+
Surgical technique∆ 
Surgical approach 
Implant details
Fixation method 
Anesthesia type°
Blood loss°
Incision length°
Local Complications
Adverse events*
Costs*
Radiographs°
+ SHAR only 
° Harris Joint Registry (HJR) only 
∆ Aggregated hospital level in the SHAR and surgery specific in the HJR 
* Data obtained via linkage studies
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of  new implant designs and materials for arthroplasty is 
ongoing and ever changing. Ideally, new technologies and 
surgical techniques would be introduced to the market in 
a step-wise fashion; starting with a small closely followed 
cohort to determine early safety, followed by larger mul-
ticenter monitoring, and finally investigated on a large 
scale in a register study.68 Implementation of  new tech-
nology or surgical techniques in this way may identify 
problems in a limited number of  cases which could then 
be mitigated or eliminated from the market altogether. 
Step-wise introduction can eliminate catastrophic failure 
rather than allowing early introduction of  new technol-
ogies nationwide before they are vetted. Because of  the 
statistical power, analysis of  implants and techniques in 
a register allows for stratification of  possible cofounders 
to identify whether differences are related to the implant 
or technique in question. These observational register 
studies are not designed to determine causation, but 
rather to provide evidence-based monitoring to identify 
problems. For this reason, observational national register 
studies work in concert with cohort and randomized tri-
als, where causation may ultimately be determined. 
Traditionally, total joint replacement registers are used 
to monitor component performance with survivorship 
defined by revision. Kaplan­Meier and Cox regression 
analyses are typically used to identify sub-optimal im-
plants due to high rates of  revision. Used in this way, 
registers are useful in assessing surgical techniques and 
specific component efficacy. The pitfall of  using revi-
sion as the only endpoint or outcome of  THR is that the 
patient’s voice is not heard and neither their satisfaction 
nor their HRQoL is taken into account when assessing 
this primarily elective procedure. Surgical technique and 
component reliability are essential elements of  THR 
surgery, but the PROs are equally important when evalu-
ating efficacy of  the treatment as mentioned earlier. 
With the introduction of  PROMs, the SHAR became 
an effective tool to assess not only surgical techniques 
and component performance, but equally important pa-
tient satisfaction, their pain before and after treatment, 
and their HRQoL. 
Introduction of PROMs to the SHAR
The SHAR began the PROM program in 2002, which 
was gradually adopted and has been active nationwide 
since 2008. Preoperatively, 86% of  patients complete 
the set of  questionnaires while the response rate at one 
year follow-up is 90%.83 In order to prevent the influ-
ence of  clinic staff  on patient responses, the follow-up 
questionnaire is completed by the patient at home. They 
are asked to complete the EQ-5D, the musculoskeletal 
co­morbidity Charnley classification survey, a VAS for 
pain, and after surgery, a VAS for satisfaction with their 
outcomes after treatment. The questionnaire is admin-
istered to the patients preoperatively (excluding satis-
faction) and at 1, 6, and 10 years postoperatively. The 
EQ­5D consists of  five health dimensions: mobility, 
self-care, usual activities, pain/discomfort, and  anxiety/
depression. The patient chooses from three answer 
options for each dimension: no problems, moderate 
problems, or extreme problems. From their responses, 
a weighted health index is calculated representing the 
patient’s HRQoL. Index scores correspond to health 
states ranging from perfect health to death and to states 
worse than death. In addition to the five dimensions, the 
patient is also asked to complete a VAS of  their impres-
sion of  their overall health on that day from zero to one 
hundred (EQ VAS). The Charnley classification survey 
assesses whether the patient has unilateral hip disease 
(class A), bilateral hip disease (class B), or hip disease as 
well as other conditions which negatively influence their 
ability to walk (class C). The patient rates the level of  
their pain on the pain VAS from zero (no pain) to one 
hundred (worst imaginable pain), and after treatment, 
the patient is asked to rate their satisfaction with the 
outcomes from treatment from zero (complete satis-
faction) to one hundred (complete dissatisfaction) on 
the satisfaction VAS. The combination of  surgical data 
and patient-reported data makes it possible to establish 
whether specific risk or protective factors contribute 
signi ficantly to the patient’s life after THR.
Harris Joint Registry
The Harris Joint Registry (HJR) is a local total hip and 
knee replacement registry, maintained by the Harris 
 Orthopaedic Laboratory at Massachusetts General Hos-
pital (MGH). The HJR collects all four levels of  data 
(Table 2). The collection of  level IV radiographic  images 
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in a local registry is more logistically feasible to imple-
ment than on the national level. The PROM proto col 
in the HJR comprises the EQ­5D, the  Charnley classifi-
cation survey, a pain VAS, a satisfaction VAS, the Har-
ris hip score (HHS),66 and the University of  California 
Los Angeles (UCLA) activity score3 as the standard of  
care for all THR patients. The HHS is a disease­specific 
survey measuring the outcomes of  THR from zero to 
one hundred where 44% of  the score is associated with 
pain. The UCLA activity score rates the patient’s activity 
level on a scale from one (inactive) to ten (regular par-
ticipation in impact sports). Radiographs and PROMs 
are obtained preoperatively (excluding the satisfaction 
VAS) and at standard clinical follow-up intervals at 6 to 
10 weeks (radiographs only) and 1, 3, 5, 7, and 10 years. 
On January 1, 2012, the standard PROM protocol in 
the arthroplasty clinic at MGH was updated. All new 
patients without a history of  THR complaining of  hip 
symptoms interested in discussing THR with the sur-
geon received three additional PROMs. The arthro-
plasty service expanded the extended PROM protocol 
in September 2012 to include any patient interested in 
discussing primary THR whether they had received a 
contralateral joint replacement or not. The new proto-
col added the Hospital Anxiety and Depression Scale 
(HADS),106 the World Health Organization’s Alcohol 
Use Disorders Identification Test (AUDIT),87 and the 
Aberdeen Participation survey.77 Any individual com-
pleting the new surveys is enrolled in the program and 
is asked to complete the surveys again at subsequent 
follow-up visits. 
Benefits and Limitations of a Local Registry
The HJR is not a hospital-wide joint replacement 
 registry. It targets the arthroplasty clinic at MGH and 
captures 96% of  targeted primary procedures.6 There-
fore, it provides a useful tool for the participating clini-
cians and researchers, but cannot indicate how the insti-
tution as a whole is doing with respect to outcomes or 
surgical techniques. The ability to identify very rare out-
comes is substantially less in a local registry the size of  
the HJR than with a national registry. However, because 
of  the size, the HJR is able to collect all four levels of  
data where storage and organization of  large files like 
radiographs is not a problem. The limited number of  
surgeons contributing to the registry will also limit the 
catalogue of  implant data collected by the HJR as many 
surgeons have their preferred implant manufacturers 
and systems thus limiting conclusion that can be drawn 
about rarely used implants. 
A major challenge for the HJR is continued follow-up 
of  all registered patients. If  a patient were dissatisfied 
with treatment at MGH and required revision surgery 
or contra-lateral treatment, it is conceivable that the pa-
tient may go to a different hospital for treatment. Unless 
the hospital was affiliated with the Partners Healthcare 
system, this would not be captured by the HJR. There-
fore, success rates in the HJR are over estimated and 
the generalizability of  its data is minimized. This chal-
lenge will be the same for any institutional registry until 
a national system for tracking THR procedures is estab-
lished based on a unique patient identifier such as social 
security numbers in the United States.
The ability of  the HJR to collect both PROMs and 
radio graphs and easily associate these with surgical 
and demographic data is very powerful. Trends of  im-
plant use can be tracked with respect to radiographic 
and PROs and feedback can be provided to clinicians. 
Subse quent clinician improvement or degradation may 
then also be tracked over time.39
PROMs in the Swedish Hip Arthoplasty 
Register and Harris Joint Registry
EQ-5D
The EuroQol group’s patient-reported measure the EQ-
5D is a generic HRQoL survey used by both the SHAR 
and the HJR.25 The survey consists of  five dimen sions 
measuring different areas of  health: mobility, self-
care, usual activities, pain/discomfort, and  anxiety/
depression. In the original version of  the survey, the 
respondent chooses from three levels that define each 
dimension: no problems, some or moderate problems, 
and extreme problems. The EuroQol group developed 
a new version of  the survey giving the respondent five 
levels of  responses from which to choose: no, some, 
moderate, severe, and extreme problems.43 
The response options for the three-level can result in 
243 (35) unique health states, which in turn, can be trans-
lated into a weighted health index. Different countries 
have different index value sets that reflect response 
norms for the given population. Until recently when a 
Swedish version became available, the SHAR used the 
British value set to score the EQ-5D index. The HJR 
uses the United States value set for reporting the EQ-
5D index. The American three-level index (derived 
from time trade-off  responses) can range from -0.109 
to 1.00 where 1.00 corresponds to perfect health, 0 cor-
responds to death, and negative indices correspond to 
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health states perceived to be worse than death.1,91 The 
new five­level version has 3,125 (55) unique health states 
possible. Currently the five­level survey does not have a 
unique value set to calculate an index score, but a ‘cross-
walk’ from the three-level does exist.20,101 
Unique health states are defined by a particular com-
bination of  responses to each of  the five dimensions. 
For the three-level survey no problems in all dimensions 
would be notated as 11111, while extreme problems in all 
five dimen sions would be notated as 33333. For the five­ 
level survey, a response of  no problems in all dimensions is 
once again notated as 11111, while extreme problems in all 
five dimensions is notated as 55555, and so on. 
The final component of  both versions of  the EQ­5D 
survey is a vertical VAS assessing the patient’s subjective 
rating of  their overall health status that day on a scale 
from zero to the best possible rating of  100 (EQ VAS). 
While both the EQ-5D index and the EQ VAS are mea-
sures of  HRQoL, they measure different elements of  
HRQoL and should be considered separately.
The EQ-5D is a brief  survey making it appealing to 
both patients and clinicians. Because it is a general 
health measure, it can be used to compare populations 
and cost effectiveness across different disease and treat-
ment groups. However, the EQ-5D index in particular 
has been criticized in the literature.8,11,37,52,58,65,98 Because 
the index is bounded, it can be useful for looking at a 
snapshot of  a population at a particular point in time, 
but unfortunately, if  one were interested in measuring 
change over time or after a particular intervention, floor 
or ceiling effects may cause limitations. For example, if  
an individual had a high EQ-5D index prior to treat-
ment, they would have very little room for improvement 
resulting in a ceiling effect. Conversely, an individual 
with a relatively low HRQoL would have a much greater 
capacity for improvement. Thus making the magnitude 
of  change highly dependent upon where the patient be-
gan on the scale. Another challenge with the EQ-5D 
index is that despite describing it as a continuous scale 
between the bounds, the index for some value sets be-
haves more ordinal in nature with patients clustering at 
certain index values. In a population of  OA patients eli-
gible for THR in Sweden, British value set indices of  0.1 
and 0.7 were very common.83
Each of  these challenges, the bounded index possibly 
leading to floor or ceiling effects and the multi modal 
distri bution of  indices need to be accounted for when 
performing statistical analyses of  the EQ-5D index which 
rarely happens. An additional challenge with the original 
EQ-5D-3L version was whether with three response 
 options, the survey was sensitive enough to pick up 
changes in fairly healthy populations such as those  eligible 
for THR due to the aforementioned ceiling effects.
Correlation and regression are the most common meth-
ods used to analyze EQ-5D data. Neither correlation 
nor regression alone are able to handle bi- or multi-
modal distributions of  EQ-5D indices. It is important 
to find the right structural relationship between the pre­ 
and postoperative EQ-5D indices when investigating 
this outcome measure. 
Pain VAS
The pain VAS is implemented pre- and postoperative-
ly in the SHAR and the HJR. The Swedish version of  
this survey ranges from zero to 100 where 100 is the 
respondent’s worst imaginable pain. For the HJR, the 
scale ranges from zero to 10, but follows the same trend 
as the Swedish version where a rating of  10 corresponds 
to the respondent’s worst imaginable pain. Zero on both 
scales represents no pain. 
Satisfaction VAS
The postoperative satisfaction VAS is the last common 
PROM between the SHAR and the HJR. Like the pain 
VAS, the satisfaction VAS is displayed horizontally, and 
in Sweden, it ranges from zero to 100 while at MGH, 
it ranges from zero to 10. For each version, zero corre-
sponds to complete satisfaction and the high end of  the 
scale corresponds to the greatest level of  dissatisfaction 
with the outcomes from treatment.
Harris Hip Score 
The hip­disease specific Harris hip score developed by 
Dr. William H. Harris of  the HOL in 1969 is a standard 
survey given to all hip patients in the arthroplasty clinic 
at MGH.40 The score was not originally designed for a 
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THR population, but is one of  the most broadly used 
outcome measures in the THR literature. The scale has 
a maximum of  100 points consisting of  four domains: 
pain (up to 44 points), hip function (up to 47 points), 
deformity (up to 4 points), and range of  motion (ROM) 
(up to 5 points). The original Harris hip score was 
staff-administered, but has since been converted into a 
self-reported survey.66 The deformity domain was origi-
nally included to account for patients who had major de-
formities due to traumatic arthritis. Because this domain 
rarely applies to standard THR patients, it was set as a 
constant, and therefore, the lowest possible self-admin-
istered Harris hip score is 4. The ROM domain was also 
standardized for the self-administered survey providing 
up to 5 points to the overall score (possible points are 
0, 3, or 5). Because it is unreasonable to ask the patient 
to define their ROM, the allotted points for this domain 
are established based upon the response combination 
to the shoes/socks and sitting questions. Traditionally, 
postoperative Harris hip scores below 70 indicated poor 
hip outcomes. It can be seen in the literature that fair 
outcomes had scores from 70 to 80, good outcomes had 
scores from 80 to 90, and scores from 90 to 100 were 
considered excellent outcomes. However, categoriza-
tion of  scores is misleading and should be a practice 
of  the past. Because outcome scores are so dependent 
upon their case mix and their preoperative score, they 
should not be categorized in this way. For this reason, 
the  Harris hip score in paper VI was treated as a con-
tinuous variable.
Despite the extensive use of  the Harris hip score, the 
survey has critics. The score shows high rates of  ceiling 
effects in THR patients. For this reason, its usefulness 
for measuring relevant changes after THR is ques-
tioned.102 At its introduction to the literature in 1969, the 
Harris hip score was not properly vetted through what 
are now considered standard psychometric tests for 
health questionnaires looking at validity, reliability, and 
responsiveness (Table 1). It was compared to two rating 
systems common at the time the Larson and Shepard 
systems, but only for score distributions.59 Given that 
there are high rates of  ceiling effects in THR patients 
today, the content validity of  this measure could be 
questioned. As pointed out by Wamper and colleagues, 
the Harris hip score probably had very good content 
validity in the population for which it was designed, but 
indications for THR have changed since 1969 and it 
may not measure as much as was originally intended.102 
Groups have however reported good construct validity 
for the Harris hip score with comparisons to the West-
ern  Ontario and McMaster Universities  Osteoarthritis 
Index, the Short Form 36, and the Nottingham Health 
Profile.30,94,95 Söder man and Malchau found the staff-ad-
ministered version of  the score to be reliable after test-
ing and retesting.94 
University of California Los Angeles (UCLA)  
Activity Score
The UCLA activity score is a standard survey adminis-
tered to all hip and knee patients in the arthroplasty 
clinic at MGH. It consists of  a single question asking 
the respondent to identify their most appropriate acti-
vity level. The score ranges from 1 (wholly inactive; 
dependent on others; cannot leave residence) to 10 
(regularly participate in impact sports such as jogging, 
tennis, skiing, acrobatics, ballet, heavy labor, or back-
packing).3 Like the Harris hip score, this measure was 
originally presented in a paper investigating a specific 
patient popu lation, and as it is presented in the paper, no 
psychometric tests were performed during the design or 
implementation of  the survey. 
Since the introduction of  the UCLA activity score, groups 
have looked at some of  the psychometric quali ties of  the 
survey. Naal and collaborators concluded that the UCLA 
activity score was reliable, feasible, and valid for use in 
THR patients.73 However, they drew these conclusions 
based on only weak or moderate corre lations with hip dis-
ease specific measures commonly used for THR patients 
and with references to Zahiri and colleagues who used in-
vestigator administered UCLA activity score surveys.73,105 
Zahiri’s group did ask the patient to rate their activity, but 
this was done on a VAS ‘relative to other people’ rather 
than with the UCLA activity score itself. Ultimately these 
measures were correlated, but correlations were weak.105 
Many agree that some measure of  activity is important in 
assessing THR outcomes and success, but no gold-stan-
dard exists.7,73,105 In order to minimize the burden on the 
patient, the UCLA activity score was the brief  survey se-
lected to do this in patients at MGH.
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Aberdeen Participation Survey
The Aberdeen participation survey is one of  the in-
cluded instruments in the new PROM protocol for the 
arthro plasty clinic at MGH.77 This survey consists of  
nine questions investigating how the respondent’s hip 
condition influences participation in activities of  daily 
living. According to the International Classification of  
Functioning, Disability, and Health three areas of  health 
outcomes should be explored when using PROMs: 
Impair ment, activity limitation, and participation re-
striction.76 Pollard and colleagues developed a measure 
for each domain which could work either in conjunction 
with one another for patients with arthritis or as stand-
alone measures.76,77 Impairment and activity were already 
covered in the standard PROM protocol in the HJR 
with the Harris hip score and the UCLA activity score 
and therefore only the Aberdeen participation survey 
was implemented so as not to over burden patients with 
redundant questions. Scores range from 9 to 45 where 9 
represents an individual with no apparent participation 
restriction, and those with 45 have extreme participation 
restriction due to their joint disease. At present, no cut 
points have been published establishing ranges for low, 
medium, or high participation restriction.
PROM Summary
Due to the national coverage of  the SHAR the PROM 
protocol was purposefully kept brief  (11 questions) to 
minimize the burden on patients and increase the re-
sponse rate.83 The HJR puts a greater burden on the 
patient with 20 questions for the original protocol and 
up to 53 questions with the addition of  the surveys for 
new patients. The HJR predominantly collects PROMs 
electronically when the patient comes to the clinic for 
follow-up while the SHAR uses paper forms mailed 
to the patients at their designated follow-up intervals. 
The HJR hopes to transition to an email based system 
where PROMs are collected whether the patient returns 
for follow-up or not; however this has not successfully 
been implemented as of  yet. It is likely that the HJR will 
have to minimize the number of  surveys administered 
or questions asked in order for the email system to be 
successful. Results presented in paper VI suggest that 
some surveys may not contribute significantly to pre-
dicting who will be recommended for THR or who will 
decide to move forward with the treatment, but those 
measures may prove to be useful in predicting who will 
have successful outcomes, and therefore have not been 
removed from the protocol yet.
Patient-reported Comorbidity 
 Screening Instruments in the SHAR 
and HJR
Charnley Classification Survey
The patient­reported Charnley classification survey is 
used by both the SHAR and the HJR. The questions 
in this survey identify the musculoskeletal comorbid-
ity status of  a patient based on the classifications de-
fined by Sir John Charnley.14 Individuals with unilateral 
hip  disease are classified as A. Those with bilateral hip 
 disease are classified as B, and anyone with multiple joint 
disease or other problems that inhibit the individual’s 
walking ability are classified as C. Some have argued 
that class B should be divided into two separate groups 
accoun ting for those who have one side or the other al-
ready treated, but this has not been sufficiently support-
ed in the literature. It is also possible that the surgeon 
can assign a Charnley classification to a patient based on 
their clinical assessment, and therefore, readers of  THR 
literature should be cognizant of  which version of  this 
musculoskeletal comorbidity classification system was 
implemented.
Hospital Anxiety and Depression Scale (HADS)
The HADS survey is part of  the new PROM protocol 
in the arthroplasty clinic at MGH. All new preoperative 
hip and knee patients are enrolled in the new PROM 
protocol and receive this survey at their first visit to the 
clinic and will again receive it at all subsequent visits. 
The survey was developed for patients in non-psychiat-
ric hospital departments.106 It is broken into two pieces 
assessing anxiety and depression separately and pro-
viding a summary score for each.106 There are fourteen 
questions; half  dedicated to the anxiety subscale and the 
other half  to the depression subscale. Scores on both 
subscales range from zero to 21. Scores up to 7 are indi-
cative of  ‘non-cases’, scores from 8 to 10 are doubtful 
cases, and scores of  11 or greater are definite cases with 
low rates of  false positives.106 
This survey was added to the HJR PROM protocol as 
a means for the arthroplasty clinicians to screen for 
 patients who may be experiencing anxiety or depressive 
disorders. Patients with depression tend to have less 
pain reduction and are less satisfied after surgical treat-
ment.81,89 By screening for these patients before surgery, 
the clinician can discuss this risk with the patient before 
undergoing THR.
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Alcohol Use Disorders Identification Test (AUDIT)
The WHO AUDIT survey is one of  the measures in-
cluded in the new PROM protocol for the arthroplasty 
clinic at MGH. The survey screens respondents for risky 
alcohol use implementing up to ten questions. If  the re-
spondent were to indicate that they do not drink alco-
hol on the first question, the respondent answers two 
more questions and the survey ends. For those who do 
consume alcohol, the system administers the complete 
ten-question survey. The scores can range from zero to 
40. Individuals whose score is from zero to 8 are re-
garded as safe alcohol users, 8 to 15 may have a medi-
um level of  alcohol problems, and scores above 16 may 
indi cate a high level of  alcohol problems.87
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Study Objectives
These works aim to investigate and describe several patient factors associated with PROs after THR as 
well as identify differences among individuals who are indicated and opt to undergo THR and those who 
do not. The specific objectives were to:
• Explore how socioeconomic, marital, and comorbid health statuses are associated with patient-reported 
HRQoL, pain, and satisfaction with THR one year after surgery.
• Understand whether mental health status and treatment of  mental health conditions are associated with 
 patient-reported HRQoL and pain before and after treatment of  OA with THR as well as if  they are 
 associated with the patient’s satisfaction with the outcome of  THR one year after treatment. 
• Investigate multiple models to improve the analysis of  EQ­5D index profiles for use in clinical outcomes 
 studies both preoperatively and postoperatively.
• Validate whether the new five­level version of  the EQ­5D survey will provide a more discriminating  measure 
of  patient-reported HRQoL in THR patients by adding intermediate response options to the previous 
three-level version.
• Calculate the probability that a patient is indicated and will be recommended for THR and whether they will 
move forward with the procedure after considering demographics and radiographic signs of  arthritis as well as 
patient-reported HRQoL, pain, function, mental health, alcohol use, and participation in daily activities.
Aims
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Patients
Swedish Hip Arthroplasty Patients
Primary THR patients with a diagnosis of  OA from the 
SHAR were the focus of  the first four papers. Partici­
pa tion in the pre- and postoperative PROM program 
was required and patient age at surgery, gender, and 
Charnley classification noted. Data from the SHAR was 
merged with Swedish National Patient Register, the Pre-
scribed Drug Register at the National Board of  Health 
and Welfare and Statistics Sweden via the unique patient 
identifier. Linkage of  these national registers provided 
additional information about medical comorbidities, 
antidepressant drug prescriptions and utilization, educa-
tion attainment, and marital status. 
The inclusion criteria for the first four papers were 
similar. Individuals in the SHAR had to have complete 
preoperative and 1 year postoperative PROMs. These 
included EQ­5D, Charnley classification survey, pain 
VAS, and satisfaction VAS (at one year). They could not 
have a revision within 1 year of  their surgery (excluding 
paper I), and for bilateral patients, only the first hip with 
complete pre- and postoperative PROMs was included 
in the analyses.
Paper I
Individuals included in paper I had surgery between 
January 2002 and December 2007. These cases were 
merged with the Swedish National Patient Register to 
obtain any other diagnoses beyond the patient’s hip OA 
as a means to calculate three of  the International Clas-
sification of  Disease­based comorbidity measures: Elix-
hauser, Charlson, and the Royal College of  Surgeons 
(RCS) Charlson. 
Paper II
Those included in paper II had surgery between Janu-
ary 2005 and December 2007. These cases were merged 
with the Swedish National Patient Registry to obtain 
comorbid conditions, and the cases were also merged 
with data from Statistics Sweden to obtain the individ-
uals’ highest level of  education and the patients’ marital 
status. The Charlson’s comorbidity index was calculated 
for all patients up to two years before THR.
Paper III
Patients had surgery between July 2006 and December 
2007 in paper III. These cases were merged with the 
Prescribed Drug Register to determine which THR pa-
tients purchased antidepressant medications up to a year 
before surgery. The Prescribed Drug Register began re-
cording all prescription purchases in Sweden in July 2005 
which is what limited the THR patient inclusion criteria. 
Paper IV
Inclusion criteria were most broad for paper IV where 
all THR patients operated between January 2002 and 
December 2011 with pre- and postoperative PROMs 
and no revisions or death within the first year after sur-
gery were included in the analysis.
Table 3.  Patient Population Counts  
for Each Paper
Paper Number Number of Patients Patient Source
I 22,263 SHAR
II 11,464 SHAR
III 9,092 SHAR
IV 36,625 SHAR
V 127 MGH
VI 325 MGH
WHO SHOULD HAVE TOTAL HIP REPLACEMENT
22
All cases without
reoperation or death
113,650
Lacking PROM data*
48,966 THRs
All primary THRs
for OA from the SHAR from 
January 2002 thru December 2011
118,156
Revision, reoperation, or death
1 year from surgery
4,506 THRs
Cases from 
January 2008 thru December 2011
and those with more than 1 hip
42,421 THRs
Cases from
January 2002 thru December 2004
5,771 THRs
All cases with complete
PROM data
64,684
All cases with the most 
common approach and 
component combination
36,625
All cases from
January 2002 thru December 2007
with 1 valid hip
22,263
Cases from
January 2002 thru June 2006
12,631 THRs
All cases with complete
PROM data
64,684
All cases with the least common 
surgical approach and
component combination
28,059 THRs
Received excluded medication
540 THRs
All cases from
July 2006 thru December 2007
9,632
All cases with appropriate NO6A
medication or none
9,092
All cases with education data
11,464
All cases from
January 2005 thru December 2007
16,492
Missing education status
5,028 THRs
Included in
Paper IV
Included in
Paper I
Included in
Paper III
Included in
Paper II
Figure 1.  Patient Selection from the Swedish Hip Arthroplasty Register
*The SHAR PROM program began in 2002 at 11 hospitals. Participation gradually increased until 2008 when it was active nationwide.
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Massachusetts General Hospital Patients
Paper V
Individuals were prospectively recruited for the vali-
dation of  the EQ-5D-5L survey presented in paper V. 
Patients complaining of  hip problems who had yet to 
undergo THR and those who were 1 to 6 years post 
THR surgery without a revision were invited to par-
ticipate. The patient-reported HRQoL of  the patients 
who agreed to participate did not differ from those of  
the patients who did not. Fifty preoperative and seven-
ty postoperative participants were required to compare 
response trends from the EQ-5D-3L survey to the EQ-
5D-5L version.
Paper VI
All patients complaining of  hip problems participating 
in the new PROM protocol in the arthroplasty clinic at 
MGH between January 2012 and December 2013 were 
considered for the analysis in paper VI. They could not 
have had an earlier THR on the side for which they were 
visiting the clinic, and the clinician had to determine that 
the problem they were encountering was in fact due to 
their hip and not referred pain due to another musculo-
skeletal problem.
Massachusetts General Hospital Bulfinch Building in Boston. Contained within this building is the Ether Dome; the location of   
the first public use of  ether as a surgical anesthetic in 1846.
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Papers I, II, and III
The general study structure was similar for papers I, II, 
and III. The influence of  one or more patient factors on 
PRO 1 year after surgery were investigated using SHAR 
data. Linkage to other national health and demographic 
data from additional national registers in Sweden facil-
itated these works. All national register data was pro-
spectively collected according to their own protocols 
and therefore these were all observational studies.
Table 4.  SHAR Linkage Studies
National Register Used Paper I Paper II Paper III
Swedish Hip Arthroplasty Register X X X
Swedish National Patient Register X X
Statistics Sweden X
Prescribed Drug Register X
Four national databases were utilized for papers I through III. 
Patients from the SHAR were linked to information in the other 
databases via a national patient identification number.
Paper IV
While the study aims were different for paper IV, the 
data utilized for illustrative purposed was collected in 
the same way as papers I through III from the SHAR. 
As a means to investigated alternative ways to present 
changes in EQ­5D index data we aimed to find the 
‘right’ structural relationship between the pre- and post-
operative EQ-5D indices to obtain the best estimation 
of  the effect of  the preoperative score on the postop-
erative score. Four models were investigated. The first 
was a null model which only had an intercept, next was 
a single line model, then a 2 line model with single tran-
sition point, and finally we looked at 3 line model with 
2 change points.
Paper V
Individuals who agreed to participate in the validation 
of  the EQ-5D-5L survey, which was detailed in paper V, 
were asked to complete both the old and new versions 
Methods
of  the survey to determine if  the newer version was 
equally or more sensitive for determining the patient’s 
HRQoL. There were at least two weeks between the 
survey version administrations and half  of  the enrolled 
patients did the EQ­5D­3L first and the other half  did 
the EQ­5D­5L first. At the point of  recruitment in the 
arthroplasty clinic at MGH, the first survey was com-
pleted either on a tablet or at a touchscreen kiosk. The 
patient then selected their preferred method for com-
pletion of  the second survey either by a paper form in 
the mail or via a secure link sent to their email. Individu-
als who failed to complete the second survey in a timely 
manner were contacted by phone to confirm that they 
were interested in continued participation. This usually 
motivated the patient to complete the second survey.
Paper VI
In paper VI, once the pre-surgery individuals who par-
ticipated in the new PROM protocol were identified in 
the HJR, several additional data points were collected 
from either the registry or the medical record: age, gen-
der, marital status, ethnicity, education, and body mass 
index (BMI). Anterior/posterior (AP) pelvis radio-
graphs were obtained when available and AP hip images 
were used if  the pelvis image did not exist in the HJR. 
The minimal joint space width (JSW) was measured on 
the hip of  interest and the severity of  OA was grad-
ed according to Tönnis.99 Where 0 was no OA, 1 was 
mild OA, 2 was moderate OA, and 3 was severe OA. 
The office visit notes were reviewed for all patients and 
the surgeon’s recommendation was documented. These 
recommendations were categorized in three ways; THR 
was recommended, THR was not recommended now, or 
THR was not recommended at all. Reasons for delaying 
a THR recommendation included the need to control 
other risk factors such as weight loss or smoking or drug 
use cessation, their symptoms were not bad enough to 
warrant surgery yet and non-operative treatment was 
recommended, or further work up was necessary to de-
termine if  their hip was in fact the cause of  their prob-
lems. THR was not recommended to individuals who 
had risk factors that made major surgery too dangerous 
or the patient’s problems were not due to their hip.
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Papers I, II, and III
The first three papers implemented linear regression anal-
yses where PROs (EQ-5D index and EQ VAS, pain VAS, 
and patient satisfaction with the outcomes of  THR) were 
the dependent variables. The various  papers explored dif-
ferent patient demographic variables as well as preopera-
tive HRQoL and pain as the dependent variables. Assess-
ment of  coefficients and confidence intervals determined 
the level of  association of  each signifi cant variable on 
the outcomes. Each of  the first three papers included pa-
tient­reported Charnley classification in the tested models 
in addition to the demographic variables of  most interest: 
paper I looked at the influence of  the International Clas-
sification of  Diseases (ICD)­based comorbidity measures 
(Elixhauser,  Charlson, and RCS Charlson); paper II ex-
plored the influence of  the patient’s highest level of  edu-
cation, their marital status, age, and gender; and in paper 
III the models  accounted for age, gender, self-reported 
anxiety and  depression, and whether the patient took an-
tidepressant medication up to 1 year before THR surgery.
The regression analyses used in paper I included the 
three ICD-10-based comobidity measures, Charnley 
classification, and the preoperative score of  the out-
come in question as the independent variables. No other 
patient demographic variables were included in the fi-
nal analysis for two reasons. First, gender and age each 
contributed less than 1% to the predictive power of  the 
models, and second, we wanted to find the  greatest pre-
dictive power contributed by the ICD-10-based comor-
bidity measures. Therefore, gender and age were exclud-
ed from these analyses. 
Statistical methods
Papers II and III implemented some subtle differences 
in their statistical methods. Paper II, looking at the in-
fluence of  education attainment and marital status on 
the outcomes of  interest, used Bayesian model averag-
ing to identify the significant predictors of  each out-
come parameter allowing the models to include only 
significant independent variables with posterior prob-
abilities of  0.50 or greater.33,47,54,79 This process identi-
fied both the EQ­5D index as well as the EQ VAS as 
independent predictors; therefore, each model includ-
ed both measures of  HRQoL. Paper III, investigating 
the influence of  antidepressant prescription usage on 
PROs, also implemented Bayesian model averaging 
to select the influential variables for each regression 
 model.  Paper III however tested each model with two-
line linear  regression splines to determine if  a change 
point should be implemented accounting for patients 
with a low or high preoperative health status as detailed 
in paper IV. The EQ-5D index was the only model that 
benefited from using the piecewise linear regression 
splines with a change point at a preoperative EQ-5D 
index of  0.051. 
Paper IV
Paper IV differed from the first three in that it was a 
methodological investigation of  how to treat the pre-
operative EQ-5D index variable when conducting linear 
regression modeling for outcomes research. The paper 
explored four regression models to determine which 
model best predicted outcomes in an OA population 
from the SHAR as the example. This methodology is 
useful for modeling the pre-treatment EQ-5D index 
Table 5.  Statistical Tests Utilized for Each Project
Statistical Tests
Paper Linear 
 Regression
Bayesian  
Model 
 Averaging
Piecewise 
Splines
Correlations McNemar’s 
Test
Random 
Forest
Flexible 
 Discriminant 
Analysis
I X
II X X
III X X X
IV X X
V X X X
VI X X X
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in populations where HRQoL is expected to improve 
and that the HRQoL before treatment will influence 
HRQoL after treatment.
Paper V
In paper V where responses to EQ-5D-5L survey 
were compared to those from the EQ-5D-3L ver-
sion, response trends were compared on a case by case 
 basis. Ceiling and floor effects were investigated using 
 McNemar’s test for each dimension and for the surveys 
as a whole. To test convergent validity of  both versions 
of  the survey, Spearman’s rank correlation coefficient 
was calculated between the EQ VAS scores between the 
two survey versions and with each of  the five dimen­
sions of  the corresponding survey version. Finally, 
the change in EQ VAS from one version to the next 
was modeled in two linear regression  models. First, 
against the response trends (same, new, or diffe rent) for 
each of  the fives dimension and second, against the 
time between the administrations for both the pre-
operative and postoperative groups where both models 
controlled for the order with which the versions were 
administered. 
Paper VI
In the final paper, thirteen different algorithms were 
tested to determine which had the best predictive power 
to determine the probability of  whether a patient would 
be recommended for THR and also the probability that 
the patient would move forward with the surgery. The 
thirteen tested algorithms could be classified in three 
ways: linear classification, nonlinear classification, and 
classification trees and rule­based models. Predictive 
power was determined by four measures of  accuracy. 
The area under the curve (AUC) was compared for each 
model, as were the sensitivity, the specificity, and the 
negative and positive predictive values as a means of  
identifying the best model for our dataset.
Centre of  registries, Västra Götaland, Gothenburg, Sweden. The house has 27 National Quality Registries (SHAR included) and is 
one of  six centers in Sweden that support and help develop additional registers.
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Paper I
Standard comorbidity measures do 
not predict patient-reported outcomes 
1 year after total hip arthroplasty: 
Charnley class better predictor of 
outcomes
This study compared the predictive capacity of  three 
measures of  comorbidity (Elixhauser’s, Charlson’s, and 
Royal College of  Surgeons [RCS] Charlson’s) at 1, 2, and 
5 years before surgery to the musculoskeletal measure 
of  comorbidity the Charnley classification for patient­re-
ported HRQoL, pain, and satisfaction 1 year after THR.
Results
Of the measures of  comorbidity considered, only the 
Charnley classification was significantly associated with all 
PROs. In fact, the RCS Charlson comorbidity score had 
no significant associations with any of  the PROs (Table 6). 
Regardless of  the timeframe used to calculate the ICD-10- 
based comorbidity scores, Charnley classification and both 
preoperative measures of  HRQoL were the  strongest pre-
dictors for the postoperative HRQoL.  Charnley classifi-
cation and the preoperative pain VAS were the strongest 
predictors for the postoperative pain VAS in all time-frame 
Summary of Papers
Table 6.  Influence of Variables on Patient-reported Outcomes 
Measure EQ-5D index EQ VAS Pain VAS Satisfaction VAS
coeff. CI95 coeff. CI95 coeff. CI95 coeff. CI95
Intercept 0.785 0.778, 0.791 71.727 70.938, 72.516 4.752 3.83, 5.674 13.243 12.82, 13.667
Charnley Class
 A ref ref ref ref
 B -0.064 -0.073, -0.054 -4.392 -5.196, -3.588 4.187 3.444, 4.929 2.959 2.120, 3.797
 C -0.112 -0.119, -0.105 -8.95 -9.509, -8.391 5.848 5.335, 6.36 5.431 4.854, 6.007
Charlson* -0.023 -0.035, -0.011 -3.407 -4.400, -2.414 0.688 -0.23, 1.607 0.88 -0.158, 1.918
RCS Charlson* 0.003 -0.008, 0.015 -0.016 -1.012, 0.980 0.245 -0.675, 1.166 -0.074 -1.115, 0.967
Elixhauser* -0.010 -0.015, -0.004 -0.886 -1.353, -0.420 0.522 0.091, 0.954 0.628 0.141, 1.116
Preoperative value 0.147 0.137, 0.156 0.174 0.162, 0.186 0.096 0.082, 0.111 - -
R2 0.107 0.108 0.037 0.018
* Each of  the ICD-10-based comorbidity measures were calculated 1 year before THR
models. Finally, irrespective of  the timeframe, Charnley 
classification was the strongest predictor for the post­
operative satisfaction VAS with marginal influence from 
the Elixhauser comorbidity score. For all outcomes, there 
was a gradual increase in the model’s predictive power with 
the length of  the timeframe considered when calculating 
the ICD-10-based comorbidity measures. 
Paper II
Education attainment is associated 
with patient-reported outcomes: 
Findings from the Swedish Hip 
 Arthroplasty Register
This study investigated the influence of  a patient’s high-
est level of  education, as a surrogate for socioeconom-
ic status, and their marital status on patient-reported 
HRQoL, pain, and satisfaction 1 year after THR.
Results
The majority of  patients were married (Figure 2) and 
had medium or high levels of  education (Figure 3).
BMA was used to determine which variables to include 
in each outcome analysis. Charnley classification, preop-
erative EQ-5D index, preoperative EQ VAS, and educa-
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tion level were the four variables consistently included 
in all regression models (Table 7). None of  the variables 
were excluded from all analyses, but a couple of  vari-
ables, marital status and preoperative pain scores, were 
only included in one regression model, the postopera-
tive pain VAS.
Table 7.  Variables Included in Each Regression Analysis as Selected by BMA
Patient-reported Outcomes
Predictors EQ-5D Index EQ VAS Pain VAS Satisfaction VAS
Age X X
Gender X X
Comorbidity X X
Charnley Classification X X X X
Preop EQ-5D index X X X X
Preop EQ VAS X X X X
Preop pain VAS X
Hip order X X
Marital Status X
Education level X X X X
Figure 2.  Marital Status of Patient Population Figure 3.  Education Level of Patient Population
Patients with high levels of  education reported higher 
levels of  HRQoL, lower levels of  pain, and greater sat-
isfaction than their lesser educated peers. Charnley class 
C had the greatest detrimental effect on both measures 
of  HRQoL and pain 1 year after THA, but age for those 
over 26 years had the greatest detrimental effect on 
satis faction followed by Charnley class C. 
Married
63%
Single
27%
Widow
10%
Medium
63%
Low
27%
High
20%
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Coeff. CI95
Pre EQ-5D Index 0.106 0.092, 0.120
Pre EQ VAS 0.001 0.001, 0.001
Coeff. CI95
Pre EQ-5D Index 5.151 3.943, 6.360
Pre EQ VAS 0.138 0.121, 0.154
Figure 4.  Influence of Categorical Variables  
on Postoperative EQ-5D Indices
Figure 5.  Influence of Categorical Variables  
on Postoperative EQ VAS Scores
Table 8.  Influence of Continuous  Variables  
on Postoperative EQ-5D Indices
Table 9.  Influence of Continuous  Variables  
on Postoperative EQ VAS Scores
Linear regression results with the slope coefficients  (coeff.) and the 95% confidence intervals (CI95) for 
each variable. 
Figure 4 and Table 8 
Preoperative HRQoL had significant influence on postoperative 
HRQoL. Men and those with high levels of  education had more 
 favorable postoperative scores, while those with musculoskeletal 
 comorbidities did worse.
Figure 5 and Table 9 
Similar to the postoperative EQ-5D index, preoperative HRQoL 
influenced postoperative EQ VAS scores. Highly educated patients 
reported higher scores and those with musculoskeletal comorbidities 
lower scores. Gender did not influence EQ VAS reporting, but having 
the second hip done resulted in slightly lower HRQoL than those only 
having the first.
−0.15 −0.10 −0.05 0.00 0.05
Coefficient
EQ−5D Index
Coef.Variable
Men 0.023
Women ref
Sex
Yes −0.037
No ref
Comorbidities
C −0.106
B −0.065
A ref
Charnley Class
High 0.033
Medium −0.0003
Low ref
Education
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Coefficient
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Yes −4.437
No ref
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A ref
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1st ref
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Low ref
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Coeff. CI95
Age (years) 0.087 0.044, 0.129
Pre EQ-5D Index -3.058 -4.334, -1.782
Pre EQ VAS -0.047 -0.063, -0.031
Pre Pain VAS 0.041 0.018, 0.065
Coeff. CI95
Age (years) 0.170 0.121, 0.219
Pre EQ-5D Index -2.363 -3.673, -1.054
Pre EQ VAS -0.060 -0.078, -0.042
Figure 6.  Influence of Categorical Variables  
on Postoperative Pain VAS Scores
Figure 7.  Influence of Categorical Variables  
on Postoperative Satisfaction VAS Scores
Table 10.  Influence of Continuous Variables  
on Postoperative Pain VAS Scores
Table 11.  Influence of Continuous Variables  
on Postoperative Satisfaction VAS Scores
Categorical variables with a coefficient of  zero acted as the reference. Confidence intervals which include 
zero indicate patient demographics that were not significantly different from the reference category.
Figure 6 and Table 10 
Postoperative pain was less in individuals with high education, high 
preoperative HRQoL, and low preoperative pain. Individuals with 
musculoskeletal comorbidities and those who were single tended to have 
greater postoperative pain.
Figure 7 and Table 11 
Men, those with high levels of  education, individuals classified as 
Charnley A, and those with high HRQoL before surgery were the 
most satisfied with the outcomes from their THR surgery.
−6 −4 −2 024   6
Coefficient
Pain VAS
Coef.Variable
C 5.543
B 4.701
A ref
Charnley Class
Married −1.902
Widow −1.337
Single ref
Marital Status
High −3.321
Medium −0.301
Low ref
Education
−6 −4 −2 024 6
Coefficient
Satisfaction VAS
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Men −1.922
Women ref
Sex
C 4.586
B 3.255
A ref
Charnley Class
2nd 1.959
1st ref
Hip Order
High −2.367
Medium 0.085
Low ref
Education
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Paper III
Does the use of antidepressants 
 predict patient-reported outcomes 
 following total hip replacement 
 surgery?
This study looked at the influence of  the use of  anti-
depressant medication up to one year before THR on 
patient-reported HRQoL, pain, and satisfaction 1 year 
after surgery.
Results
Patients using antidepressants had poorer HRQoL and 
higher levels of  pain before and after THR and on av-
erage experienced less satisfaction from the treatment. 
Ten percent of  the population (n=943) acquired an-
tidepressant medication at least once during the pre-
operative period. Unfortunately over a third of  these 
individuals had no text indicating the reason for the pre-
scription (Figure 8) therefore this information could not 
be included in the regression models. The majority of  
anti depressant patients obtained their medication con-
tinuously throughout the observation period (Figure 9). 
The prevalence of  antidepressant usage increased with 
the self-reported anxiety/depression severity in the 
fifth dimension of  the preoperative EQ­5D survey 
(Figure 10). 
Figure 10.  Proportion of Responses to 
 Preoperative EQ-5D Anxiety/Depression Dimension
Figure 8.  Diagnoses for Antidepressant 
 Prescriptions
Figure 9.  Antidepressant Medication  
Usage Patterns
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Table 12.  Variables Included in Each Regression Analysis as Selected by BMA
Patient-reported Outcomes
Predictors EQ-5D Index EQ VAS Pain VAS Satisfaction VAS
Age (years) X X X X
Gender X
Charnley Classification X X X X
Preoperative EQ-5D Index X X
Preoperative EQ VAS X X X X
Preoperative Pain VAS X X
Hip Order
5th Dimension of EQ-5D X X X X
N06A* X X X
Usage* X X
* The models were tested with either the dichotomous antidepressant variable (N06A) or the categorical antidepressant usage variable (usage) 
at one time. All other variable posterior probabilities remained the same regardless of  whether the N06A or usage variable was included.
After BMA, Charnley classification, preoperative EQ 
VAS, and the fifth dimension of  the preoperative EQ­
5D were the four variables consistently included in all 
regression models (Table 12). Hip order was not signifi-
cant for any of  the analyses.
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Coeff. CI95
Age (years) -0.233 -0.271, -0.194
Pre EQ-5D Index 2.645 1.218, 4.072
Pre EQ VAS 0.121 0.102, 0.140
Figure 12.  Influence of Categorical Variables  
on Postoperative EQ VAS Scores
Table 14.  Influence of Continuous Variables  
on Postoperative EQ VAS Scores
Figure 11 and Table 13 
The EQ-5D index was the only model that benefited from the use of  
piecewise linear regression splines with a change point at a preoperative 
EQ-5D index of  0.051. Individuals with preoperative EQ-5D index 
values less than 0.051 had low preoperative HRQoL while those with 
index values of  0.051 or greater, had high pre operative HRQoL. 
Figure 12 and Table 14 
Usage trends only influenced the EQ-5D index and EQ VAS.  
Of  the various usage trends, increased antidepressant dosages had the 
greatest negative influence on EQ-5D indices at 1 year. Conversely, 
increased dosage was the only usage trend that was not associated with 
the patient-reported EQ VAS at 1 year.
Coeff. CI95
Age (years) -0.002 -0.002, -0.001
Pre EQ-5D Index
 Low 0.497 0.296, 0.698
 High 0.034 0.014, 0.055
Pre EQ VAS 0.001 0.0006, 0.0010
Pre Pain VAS -0.001 -0.0009, -0.0003
Figure 11.  Influence of Categorical Variables  
on Postoperative EQ-5D Indices
Table 13.  Influence of Continuous Variables  
on Postoperative EQ-5D Indices
Linear regression results with the slope coefficients  (coeff.) and the 95% confidence intervals (CI95) for 
each variable. 
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Coeff. CI95
Age (years) 0.083 0.047, 0.119
Pre EQ VAS -0.045 -0.062, -0.027
Pre Pain VAS 0.058 0.036, 0.079
Coeff. CI95
Age (years) 0.207 0.165, 0.249
Pre EQ VAS -0.043 -0.062, -0.024
Figure 13.  Influence of Categorical Variables  
on Postoperative Pain VAS Scores
Figure 14.  Influence of Categorical Variables  
on Postoperative Satisfaction VAS Scores
Table 15.  Influence of Continuous Variables  
on Postoperative Pain VAS Scores
Table 16.  Influence of Continuous Variables  
on Postoperative Satisfaction VAS Scores
Categorical variables with a coefficient of  zero acted as the reference. Confidence intervals which include 
zero indicate patient demographics that were not significantly different from the reference category.
Figure 13 and Table 15 
Antidepressant medications were associated with increased patient- 
reported pain at one year, but those reporting severe anxiety/depression 
on the preoperative EQ-5D survey also reported significantly higher 
postoperative pain.
Figure 14 and Table 16 
Antidepressant prescriptions were not associated with satisfaction 
with outcomes 1 year after surgery. However, self-reported anxiety/
depression was associated with satisfaction as much as or more than 
the presence of  additional musculoskeletal comorbidities.
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Paper IV
Improved statistical analysis of pre- 
and post-treatment patient-reported 
outcome measures (PROMs):  
The applicability of piecewise linear 
regression splines
This work explores several linear relationships to identi-
fy the best way to understand the relationship between 
preoperative scores and postoperative scores using EQ-
5D indices from the SHAR as the example.
Results
The vast majority of  the 36,625 patients studied re-
ported improved postoperative HRQoL, however there 
were patients who reported no change in their EQ-5D 
index and a proportion who actually got worse after 
THR (Figure 15).
If  the relationship between the preoperative and post-
operative scores was normally distributed, a distribution 
like that of  figure 16A would be expected; however, the 
responses were actually multimodal as shown in figure 
16B where the red arrow indicates the most common 
pre- and postoperative responses.
Regression modeling showed that a two-line regression 
equation best described the relationship between pa-
tient-reported pre- and postoperative EQ-5D indices 
(Figure 17). The estimated change-point was at EQ-5D 
Figure 16.  Distribution of Pre- and  
Postoperative EQ-5D Indices
This figure indicates the true multimodal distribution of  pre- and 
postoperative EQ-5D index scores with the red arrow indicating the 
most common combination of  repsonses
This figure indicates the distribution of  pre- and postoperative indices 
if  the relationship were normally distributed with the vertical dimen-
sion indicating the frequency of  response combinations
Figure 15.  Change in EQ-5D Indices from 
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Figure 17.  Distribution of Pre- and  
Postoperative EQ-5D Indices with Two-line 
 Piecewise Linear Regression Splines
index 0.159 (95% CI: 0.135, 0.182) as indicated by the 
dotted line. Those who had a preoperative EQ-5D in-
dex of  0.159 or less were classified as having low pre-
operative HRQoL (n=13,157 (35.9 %)) and those over 
0.159 as having high preoperative HRQoL (n=23,468 
(64.1 %)).
For those with low preoperative HRQoL, each one-unit 
increase in their preoperative index resulted in an im-
provement of  0.528 (95%CI: 0.480, 0.576) in their post-
operative index. The intercept for this piece of  the linear 
regression line was 0.682 (95%CI: 0.677, 0.686), which 
indicates a trend of  postoperative improvement. 
For individuals who had a high preoperative HRQoL, 
they reported a lower rate of  improvement in the post-
operative index: 0.106 (95% CI: 0.091, 0.121). The inter-
cept for the second half  of  the linear regression line was 
0.748 (95%CI: 0.742, 0.755), also indicating a trend of  
improvement, just less dramatically so.
Paper V
The EQ-5D-5L improves on the EQ-5D-
3L for health-related quality of life 
 assessment in patients undergoing 
total hip arthroplasty
This study compared patient responses on two versions 
of  the EQ-5D survey, the original three-level and the 
new five­level, to identify if  the five­level version might 
provide a better profile of  preoperative and postopera-
tive THR patient health status.
Results
The intermediate response options in the new five­level 
version of  the EQ-5D survey were used by the majority 
of  patients in the majority of  dimensions in the preop-
erative group particularly in the dimensions most com-
monly associated with hip OA; mobility, usual activities, 
and pain (Figure 18). The postoperative patients were 
more likely to select the same answer options in four 
of  the five dimensions in both versions of  the survey, 
except for the pain dimension, where they were more 
likely to use the new responses (Figure 19).
No problems in all five dimensions on both the 
three­level and five­level surveys was the most common 
response for postoperative patients. However, for the 
pain/discomfort dimension the new responses were 
chosen 43% of  the time, which was the most common 
for this dimension for these patients.
Some patients chose response options that were more 
than one response away from their first, these were 
classified as different in both pre­ and postoperative pa-
tients. These different responses were as high as 14% 
in some dimensions in the preoperative patients and as 
high as 18% in one dimension (pain/discomfort) for 
postoperative patients.
Floor effects were not a major problem for either pa-
tient group in either survey. The only dimension with 
floor effects above 6% was in the pain/discomfort di-
mension for preoperative patients in the three-level 
survey, which was significantly decreased to 4% in the 
five­level survey (p=0.008).
Ceiling effects were diminished by the new response op-
tions in the five­level survey in all dimensions for both 
patient groups; however not all decreases were signifi-
cant. The only dimension with a significant decrease in 
The splines describe the relationships between the preoperative and 
postoperative EQ-5D indices with a single change point at the baseline 
score of  0.159. Those to the left of  the line are considered to have 
low preoperative HRQoL and those to the right high preoperative 
HRQoL.
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ceiling effects for the preoperative patients was in self-
care. Conversely, all dimensions except anxiety/depres-
sion were significantly diminished for the postoperative 
group (Figure 20).
The convergent validity between the survey versions and 
their corresponding EQ VAS was good. Change in the 
VAS score from the three­level survey to the five­level 
survey was correlated to the response patterns in the 
pain/discomfort dimension. Those reporting more pain 
from one version to the next also reported on average 13 
Figure 18.  Preoperative Patient Response Trends to EQ-5D Surveys 
points lower on the VAS (p = 0.04). Postoperative VAS 
scores also decreased as worse problems were reported 
in each of  the five dimensions, but were not found to 
be significant (all p > 0.05). With the doubling of  re-
sponse time between the survey versions, preoperative 
patients reported on average 3 units less on the EQ VAS 
(p = 0.05). Despite this difference on the VAS, there was 
no change in the relationship observed between the re-
sponse trends to the five dimensions in either group of  
patients and the completion time between the different 
survey versions.
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Preoperative patients took advantage of  the new response options in the mobility, usual activities, and pain dimensions.
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Figure 19.  Postoperative Patient Response Trends to EQ-5D Surveys 
Figure 20.  Ceiling Effects in Preoperative and Postoperative Patients 
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Postoperative patients most commonly reported no problems in both versions of  the survey except in the pain dimension where they 
utilized the new response options.
Ceiling effects were significantly diminished in only the self-care dimension for the preoperative group, but were diminished for 
mobility, self-care, usual activities, and pain/discomfort for the postoperative group.
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Paper VI
Predicting who will be recommended 
for total hip replacement and those 
who will proceed: A tool for surgical 
recommendations
The final project looked at which patient factors had the 
greatest influence on predicting whether a patient would 
be recommended for THR and also whether the patient 
would decide to move forward with surgery.
Results
Surgical Recommendations
Of  all the algorithms tested, random forest had the 
greatest predictive capacity for identifying the proba-
bility that a patient would be recommended for THR 
surgery and was therefore chosen as the selected model. 
If  the probability threshold were set to 0.5, the random 
forest model had a 0.837 sensitivity and 0.569 specifici-
ty. If  the probability threshold were optimized for both 
sensitivity (0.679) and specificity (0.751) it would be set 
at 0.653. Of  the 17 variables included in the model, JSW, 
BMI, Harris hip score, OA grade, and Aberdeen partic-
ipation had the greatest influence on whether a patient 
was recommended for surgery (Figure 21).
Those recommended for THR versus those who were 
not recommended now were older, had lower BMIs, 
narrower JWS, higher OA grades, more participation 
limitations according to Aberdeen, greater pain, worse 
HRQoL, reported less activity on the UCLA activity 
survey, and had worse hip symptoms according to the 
Harris hip score (Table 17). 
Proceeding with Surgery 
There were two models that stood out from those tested 
for predicting the probability of  a patient proceeding 
with surgery: flexible discriminant analysis and random 
forest. The area under the curve of  flexible discriminant 
analysis model was higher than that of  random forest 
(p=0.003); however, its classification accuracy was not 
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Figure 21.  Relative Influence of Each Variable on 
Surgical Recommendation
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Recommendation
Surgery Not Now p
Count 192 133
Gender – Female 103 (53.6) 82 (61.7) 0.187
Age 60.21 (10.74) 55.79 (13.59) 0.001
Ethnicity 0.842
 White 181 (94.3) 120 (93.0)
 Black 2 (1.0) 3 (2.3)
 Asian 6 (3.1) 4 (3.1)
 Hispanic 3 (1.6) 2 (1.6)
Marital Status 0.323
 Single 24 (12.6) 26 (19.7)
 Married/Partnered 139 (73.2) 90 (68.2)
 Divorced/Separated 18 (9.5) 9 (6.8)
 Widowed 9 (4.7) 7 (5.3)
Body Mass Index 27.79 (4.40) 29.37 (7.43) 0.019
Joint Space Width (mm) 0.61 (0.74) 1.47 (1.19) <0.001
Osteoarthritis Grade <0.001
 None 0 (0.0) 5 ( 4.2)
 Mild 10 (5.6) 37 (31.1)
 Moderate 80 (45.2) 49 (41.2)
 Severe 87 (49.2) 28 (23.5)
AUDIT 2.85 (3.03) 2.82 (3.46) 0.928
Aberdeen 20.90 (6.49) 18.83 (7.25) 0.008
HADS – Anxiety 5.01 (3.89) 5.33 (4.26) 0.480
HADS – Depression 4.88 (3.43) 4.36 (3.64) 0.197
Charnley Classification 0.773
 A 78 (40.6) 57 (42.9)
 B 33 (17.2) 19 (14.3)
 C 81 (42.2) 57 (42.9)
Pain VAS 5.82 (2.09) 5.22 (2.38) 0.017
EQ VAS 72.35 (18.43) 74.08 (17.86) 0.404
EQ-5D Index 0.62 (0.18) 0.66 (0.21) 0.050
UCLA Activity 4.76 (2.18) 5.40 (2.54) 0.016
Harris Hip Score 54.46 (14.45) 60.93 (18.21) <0.001
Table 17.  Patient Demographics Stratified by Surgical Recommendation
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uniformly better. Additionally, the specificity of  random 
forest was better than that of  flexible discriminant anal-
ysis; therefore, random forest was the selected model 
once again. If  the probability threshold were set to 0.5, 
the random forest model had a 0.756 sensitivity and 
0.611 specificity. If  the probability threshold were opti-
mized for both sensitivity (0.772) and specificity (0.612) 
it would be set at 0.588. Of  the 17 variables included 
in the model, JSW, HHS, the EQ-5D index, gender, 
and preoperative pain appeared to have the greatest 
influence on whether a patient proceeded with surgery 
 (Figure 22).
Those who chose to have THR versus those did not 
were older, had narrower JWS, had higher OA grades, 
had more participation limitations according to Aber-
deen, had greater pain, worse HRQoL according to the 
EQ-5D index, reported less activity on the UCLA activ-
ity survey, and had worse hip symptoms according to the 
Harris hip score (Table 18). 
Joint Space Width
Harris Hip Score
EQ-5D Index
Gender
Pain VAS
Body Mass Index
OA Grade – Severe
Aberdeen Participation Score
OA Grade – None
AUDIT Score
OA Grade – Moderate
HADS Anxiety Score
Age
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Ethnicity – Black
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Ethnicity – Asian
EQ VAS
UCLA Activity Score
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Marital Status – Divorced/Separated
Marital Status – Married/Partnered
Ethnicity – Hispanic
Marital Status – Widowed
0 20 40 60 80 10
0
Figure 22.  Relative Influence of Each Variable on 
Surgery Decision
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Proceeded with Surgery
Yes No p
Count 148 177
Gender – Female 74 (50.0) 111 (62.7) 0.028
Age 60.14 (11.91) 56.95 (12.22) 0.018
Ethnicity 0.452
 White 142 (95.9) 159 (91.9)
 Black 1 (0.7) 4 (2.3)
 Asian 3 (2.0) 7 (4.0)
 Hispanic 2 (1.4) 3 (1.7)
Marital Status 0.961
 Single 23 (15.8) 27 (15.3)
 Married/Partnered 102 (69.9) 127 (72.2)
 Divorced/Separated 13 (8.9) 14 (8.0)
 Widowed 8 (5.5) 8 (4.5)
Body Mass Index 28.20 (4.70) 28.64 (6.72) 0.505
Joint Space Width (mm) 0.61 (0.75) 1.28 (1.16) <0.001
Osteoarthritis Grade <0.001
 None 0 (0.0) 5 (3.2)
 Mild 7 (5.0) 40 (25.8)
 Moderate 65 (46.1) 64 (41.3)
 Severe 69 (48.9) 46 (29.7)
AUDIT 3.11 (3.71) 2.61 (2.71) 0.163
Aberdeen 21.25 (6.50) 19.06 (7.04) 0.004
HADS – Anxiety 5.13 (4.23) 5.15 (3.89) 0.970
HADS – Depression 4.99 (3.50) 4.39 (3.52) 0.126
Charnley Classification 0.421
 A 59 (39.9) 76 (42.9)
 B 28 (18.9) 24 (13.6)
 C 61 (41.2) 77 (43.5)
Pain VAS 6.07 (1.93) 5.16 (2.38) <0.001
EQ VAS 72.48 (17.56) 73.54 (18.73) 0.603
EQ-5D Index 0.61 (0.19) 0.67 (0.20) 0.004
UCLA Activity 4.57 (2.16) 5.41 (2.44) 0.001
Harris Hip Score 52.57 (12.89) 60.90 (17.98) <0.001
Table 18.  Patient Demographics Stratified by Surgical Decision
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SHAR Studies
Utilization of  national register data to conduct epidemio-
logical studies is a great strength of  the first four papers. 
With 100% coverage and a high level of  completeness, 
the SHAR is an invaluable tool for understanding trends 
in THR patients in Sweden. The only opportunity for 
loss to follow-up is if  a patient were to emigrate, other-
wise data from patients who move from one region of  
Sweden to another will still be captured. The use of  a 
national personal identification number is what allowed 
the linkage between the SHAR and other health registers 
and Statistics Sweden, another great strength of  papers I 
through III. The addition of  PROMs to the SHAR has 
added value to the surgical and demographic data collect-
ed therein. High response rates to the PROM program 
allow for analyses such as those in the first four papers 
to identify patient factors that could either protect them 
from or set them at a higher risk for poor outcomes after 
THR. With the inclusion of  PROs, the patient’s voice 
is considered and can influence how decision­making 
occurs and how treatment may be improved for at-risk 
patients. However, observational studies like those sum-
marized here, can only provide information about trends, 
but cannot speak to causation. While some consider this 
to be the major limitation of  observational studies, it 
could be argued that observational studies, and particu-
larly national observational studies, play a very import-
ant role in identifying rare risk factors that might not be 
identified in smaller cohort studies and randomized con-
trolled trials. With the identi fication of  these risk factors, 
targeted studies may then be executed to understand the 
causation of  the risk. 
Strengths and Limitations
MGH Studies
The HJR only covers a select group of  surgeons at a sin-
gle institution making the generalizability of  studies of  
its patients limited. However this targeted coverage does 
have its benefits allowing for the collection of  level IV 
data (radiographs). Similarly, a more extensive PROM 
program can be implemented in the clinic due to agree-
ment from all participating surgeons. Although paper 
VI does not have the benefit of  nationwide data, it is 
strengthened by access to both radiographs and an ex-
tensive PROM protocol. An unfortunate limitation for 
paper VI was the highly incomplete education data. Giv-
en that education level had an important influence on 
outcomes after THR as indicated in paper II, it was un-
fortunate that this variable could not be included in the 
analysis of  factors influencing whether surgery would be 
recommended and whether the patient would proceed. 
A strength of  paper V was the two week sepa ration 
of  survey administrations and the crossover  design of  
the study when validating the EQ-5D-5L survey unlike 
other EQ-5D-5L validation studies.17,50,51,75,88 This sepa-
ration was important to ensure that patient responses 
to one version of  the survey would not influence the 
patient’s response to the second version as occurred in 
other validation studies with the EQ-5D-5L survey.49
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These studies provide a better understanding of  demo-
graphics and risk factors that may predispose OA pa-
tients for poor outcomes after THR surgery as well as 
identify accurate methods to assess those factors and 
outcomes. Identification or confirmation of  new and 
existing factors associated with PROs is an important 
step in improving care with THR. Patients electively 
choose this procedure with the hope of  eliminating pain 
and improving their mobility. Should either of  these 
 areas not improve, it is very likely that the patient will 
be dissatisfied with their treatment and their HRQoL 
will suffer.4,24 It is important that referring clinicians and 
surgeons educate patients about their risks as well as set 
 realistic expectations for outcomes from THR. Identi-
fying patients with the risk of  poor outcomes is crucial 
before surgical intervention, particularly when non- 
surgical options are available to improve these risk fac-
tors before surgery. Identification of  patients who will 
most benefit from THR and educating those at risk for 
 poorer outcomes may ultimately improve patient satis-
faction and the cost utility of  this treatment. 
The Role of Register Studies
Because register studies cannot draw conclusions about 
causation, these works like all observational studies, act 
predominantly to discover patient factors associated 
with outcomes. Either smaller targeted cohort studies 
or randomized trials can further explore the identified 
factors. Our register studies do not seek to define how 
these patients should be treated with respect to surgical 
versus non-surgical interventions. Once again, targeted 
studies can identify whether at risk patients will have 
greater benefits from alternative, non­surgical treat-
ment, or delayed surgical treatment. This work provides 
clinicians with greater understanding of  how certain OA 
patients may do after THR. The results are not intended 
to deter surgical intervention in any at risk groups, but 
rather identify subpopulations that may benefit from 
additional education, closer investigation, and greater 
attention before and/or after surgery. Whether specific 
actions regarding these patients will improve outcomes 
requires exploration and their efficacy will need to be 
determined.
Discussion
Protective and Risk Factors
Comorbidities 
Because THR is elective, serious and life-threatening 
conditions are usually a contraindication, and therefore, 
the population eligible for the procedure tends to be 
healthy. Comorbidities are defined as conditions that are 
not associated with the development of  the condition 
or diagnosis of  interest.71 Medical conditions besides 
OA measured with the ICD-10-based comorbidity mea-
sures had a marginal influence on reported THR out-
comes, but did not prove to be valuable when predicting 
HRQoL, pain, satisfaction, or functional abilities after 
THR.60 Because these measures were designed to mon-
itor morbidity and rehospitalization, it is not surprising 
that they were not closely associated with the outcomes 
from healthy adults treated with THR.13,23,90 Muscu-
loskeletal comorbidities such as bilateral hip  disease 
(Charnley class B) or inhibited walking due to other 
joint conditions (Charnley class C) did have a detrimen-
tal effect on PRO after THR. These additional joint 
problems are unlikely to be accounted for in standard 
measures of  comorbidity because they are likely to also 
be caused by OA. When measuring pain, HRQoL, and 
satisfaction after THR, it goes to reason that additional 
untreated joints affected by OA would influence recov-
ery and reported outcomes. Therefore, when predicting 
outcomes after THR, it is important to account for mus-
culoskeletal comorbidities using Charnley classification. 
Socioeconomic Status
Socioeconomic status is determined by three elements 
occu pation, income, and education. In most cases, the 
highest level of  education attained will influence an indi­
vidual’s occupation and therefore their income.28 Once an 
individual’s education is complete, usually early in life, it 
remains constant unlike occupation and income making 
education a useful measure of  socioeconomic status par-
ticularly in health studies looking at individuals who may 
be retired or disabled and unable to work.16,38 Individuals in 
Sweden with moderate or low levels of  education tended 
to have worse HRQoL, greater pain, and less satisfaction 
after THR suggesting that  individuals with lower socio-
economic status were at a greater risk of  poor THR out-
comes. The education system in Sweden is quite different 
from that of  the United States and therefore, the influence 
of  education on health may vary between these nations. 
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Unfortunately, I was unable to explore the influence of  
education on health status before THR in the American 
population due to missing education data in the major-
ity of  patient records. However, others have also found 
that low levels of  education have a detrimental effect on 
THR outcomes.9,26,96 Despite this, patients with low levels 
of  edu cation do benefit from THR and should not be ex-
cluded from consideration by clinicians. They may simply 
benefit from additional discussions about the importance 
of  rehabilitation and postoperative expectations.
Domestic Support
Marital status was included in the analyses in papers 
II and VI as a measure of  domestic support. Because 
rehabilitation from surgery is important for favorable 
outcomes, we were interested to know if  having a do-
mestic partner had an influence on the decision to have 
THR and on how the patient would do postoperative-
ly. Marital status was among the lowest rated variables 
in predicting whether a patient would choose to have 
THR if  it were recommended. When modeling PRO at 
1 year, marital status only influenced the reporting of  
pain. These results may mean that patients have support 
systems beyond domestic partnerships or that support 
is not an important factor in deciding to have surgery or 
successful recovery. A third option is that marital status 
is simply too crude a variable to understand the complex 
nature of  social support, and qualitative investigation of  
social support might be beneficial.
Mental Health
Depression prevalence has a wide range (3.2% to 19.8%) 
depending on the population investigated.10,55,62,103 Be-
cause the prevalence of  depression and/or anxiety in 
populations with OA has been measured as high as 41% 
is it important for clinicians treating individuals with OA 
to understand how depression or anxiety might affect 
their patients.5,64,70,89 Depression is linked to reduced 
physical function, greater experience of  pain, and over-
all impairment in HRQoL in addition to the well-known 
psychological and  emotional symptoms.5,18,85,89 Physical 
symptoms of  depression are very similar to those of  
OA and could confound the diagnosis of  depression 
in patients living with OA and vice versa.85 In fact, 
OA  patients suffering from physical symptoms are at 
a  higher risk of  developing the psycho logical elements 
of  depression.100 Also important for clinicians to under-
stand is that OA patients suffering from depression have 
a greater sensitivity to pain and decreased ability to cope 
with their disease, and that depressed individuals who 
undergo surgery tend to report less satisfaction and pain 
reduction with treatment.81,85,89
Because antidepressants provide minimal improvement 
in mild to moderate depression for many patients, anti-
depressant usage may serve as a viable stand-in for depres-
sion in health studies.27,44,56,72 Antidepressant medications 
serving as a surrogate for mental health status in the Swed-
ish OA population with THR did in fact indicate that indi-
viduals prescribed these medications had worse HRQoL 
and pain before and after surgery and were less satisfied 
with the outcomes from THR. Because the indication for 
the medication was unknown in over a third of  patients, 
it unfortunately was not possible to identify if  a particu-
lar condition or  another had a greater influence on these 
outcomes. When screening for anxiety and depression 
preoperatively at MGH, neither condition played a pivotal 
role in surgical recommendations or in the patients’ deci-
sion to move forward with surgery. It will be important 
to follow the MGH patients postoperatively to determine 
the influence of  anxiety and depression independently on 
THR outcomes. Lin and collaborators showed that ar-
thritis patients receiving enhanced depression care incor-
porating antidepressants and/or psychotherapy sessions 
had marked improvements in pain, physical function, and 
HRQoL even without surgical intervention.64 Thus indi-
cating that in the case of  some patients, treatment of  de-
pression may improve their ability to cope with their OA 
even without surgical intervention. A better understand-
ing of  which specific mental health conditions influence 
outcomes after THR will allow clinicians to better target 
non-operative and surgical treatment of  OA.
ANGUISH AND HIP SURGERY
Age and Gender
Age and gender are commonly considered important 
risk factors necessitating control in health study models. 
Because the frequency of  OA increases as the popula-
tion ages, it is important to account for a patient’s age 
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when considering treatment with THR.19,82 Both papers 
II and III found that age had a significant influence on 
postoperative pain and satisfaction. When considering 
HRQoL, age was found to have a non-linear relation-
ship, and there was a detrimental effect on patient- 
reported HRQoL once individuals entered their late 
sixties.35 Interestingly, the population in paper II was on 
average five years younger (64 years) than those in pa-
per III (69 years) due to missing education data for the 
older patients. The age distribution in paper II could ex-
plain why age was not an influential variable in the post­
operative EQ-5D index and EQ VAS models, but was 
an included variable in paper III. Age is an important 
consideration when comparing THR populations be-
tween nations as well. The THR population investi gated 
at MGH was on average even younger than the two 
Swedish populations (60 years). Patients in the US get 
joint replacement at an earlier age than those in  Europe 
and tend to have better PRO after treatment, suggesting 
perhaps that  European clinicians may wait too long to 
achieve optimal outcomes.36 
Because THR is more common in women, gender is also 
important to consider when studying outcomes.41,78 Gen-
der is also known to influence functional status, HRQoL, 
and satisfaction before and after THR.9,83,92 While wom-
en reported lower HRQoL before and after THR than 
men, the change in their scores was greater suggesting 
that perhaps women may benefit from THR at a younger 
age than men. The exception to this appears to be wom-
en who are Charnley class C and had the least amount of  
improvement in HRQoL than all their peers.34 Gender 
only played a very small part in the probability of  cli-
nicians at MGH recommending THR surgery, but was 
actually among the top five variables influencing the 
probability that the patient would decide to have THR.
EQ-5D
When addressing general aspects of  health, the EQ-
5D survey and its EQ VAS should not only to be con-
sidered outcome measures, but rather the elements of  
this instrument can also serve as independently reliable 
indicators of  a patient’s health which are associated with 
the PROs. In clinical practice, the use of  these measures 
preoperatively is valuable for clinicians as a means to 
understand a patient’s self-reported health status in or-
der to more accurately encourage realistic expectations 
for the outcomes from surgery, despite neither having as 
strong a predictive power as the Charnley classification 
as found in paper I.
Three-level survey
The positive attributes of  the original EQ-5D, that it is 
short and validated in 160 languages, contribute to its 
wide use to assess HRQoL. The EQ-5D index and EQ 
VAS provide users with two measures of  HRQoL. The 
index is a weighted value based on population norms 
and preferences allowing comparisons between patient 
groups or treatment types. The index can compare 
HRQoL between groups of  patients who received THR 
and those who opted for non-surgical treatment, or be-
tween THR patients and total knee replacement patients 
for example. We are however limited to in-country com-
parisons because different values sets result in different 
index score ranges. The British value set, used in Sweden 
until the recent development of  the Swedish value set 
and utilized in papers I through IV, ranges from -0.594 
to 1.000. By contrast, the American value set ranges 
from -0.109 to 1.000, and the new Swedish value set 
ranges from 0.340 to 0.969 making comparisons across 
published works challenging, if  not impossible. In order 
to compare populations, the same value set may be used 
to calculate index scores, but the user risks inaccurate 
weighting of  the five dimensions for one or more of  
the populations. The EQ VAS is a patient-centered mea-
sure of  HRQoL in that the patient is asked to rate their 
health that day on a scale of  zero to 100. 
Because the scores from the EQ-5D survey provide 
these two different measures of  HRQoL, papers II and 
III tested both preoperative EQ-5D indices and EQ 
VAS scores with Bayesian model averaging to determine 
if  either or both should be included in the linear regres-
sion models. When looking at education, preoperative 
EQ-5D index and EQ VAS scores were included in each 
regression model looking at all four outcomes, but when 
investigating antidepressant prescriptions, the preopera-
tive EQ-5D index was not included in the postoperative 
pain VAS or satisfaction VAS models. The differences 
may be accounted for in the patient populations. While 
there is likely to be overlap between the populations in 
the two studies (Figure 1), paper II had a broader time 
interval for inclusion and a larger observed population. 
However, the posterior probabilities for the preoper-
ative EQ-5D index in paper III were zero indicating 
no direct influence of  this variable on the postopera-
tive pain or satisfaction VAS scores, so the population 
differences are unlikely to explain the exclusion of  the 
preoperative EQ-5D index in paper III. Responses to 
the final question of  the EQ­5D survey, whether the 
patient experienced anxiety or depression, did influence 
patient-reported pain and satisfaction at one year. In this 
population, inclusion of  the fifth question responses 
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seems to have taken over the role of  the EQ-5D index 
with respect to these two outcomes. Both the EQ-5D 
index and EQ VAS scores remained influential for re-
porting of  both postoperative EQ-5D indices and EQ 
VAS scores however.
Five-level survey
Several groups have validated the new five­level version 
of  the EQ-5D survey for both general and disease spe-
cific patient groups supporting broad adoption of  this 
improved instrument.46,50,51,75,88 Our findings were similar 
for the preoperative and postoperative THR popu lations 
suggesting that with five response choices, patients will 
be able to provide a more nuanced assessment of  their 
HRQoL than with the original version.  Responses to 
the five health dimensions in the EQ­5D­5L had  either 
moderate or strong correlations with the EQ VAS 
whereas correlations with the responses in the EQ-5D-
3L were weak or absent. This finding could mean that 
with the development of  a weighted index value set, 
the EQ-5D-5L index may more closely correlate with 
EQ VAS scores indicating a sharper representation of  
HRQoL with the index than with the three-level survey.
New Tools for Clinicians
The ability to anticipate and mitigate poor outcomes 
after THR will benefit patient HRQoL directly. Addi-
tionally, it could decrease the overall societal cost of  the 
treatment by delaying the procedure in some, encourag-
ing THR earlier on others, or by minimizing clinically 
unnecessary follow-up appointments in at risk patients. 
With an arsenal of  tools, the clinician can hone patient 
care preoperatively to target those who will most ben-
efit from THR and provide additional education or 
non­surgical care for patients who may not benefit in 
the near-term. Large register studies like those outlined 
here, are an important step in identifying at risk patients 
like those with additional joint problems, low levels of  
education, or active antidepressant use.
Patient Education
Many patients suffering from arthritis assume that in-
creased pain corresponds to additional injury. Therefore, 
due to fear of  further damage both before and after 
THR, some patients may reduce their activity. Contrary 
to this assumption, activity avoidance may contribute to 
physical deterioration and muscle weakness  making their 
condition worse and making it more difficult to re cover.45 
 Education is important for OA patients to under stand 
how their activity or lack thereof  will influence the  severity 
of  their condition. Poorer THR outcomes in certain 
 patient groups like those identified in papers I through 
III may be due to inadequate participation in rehabili-
tation. Several factors may be the cause; fear, low levels 
of  motivation, heightened pain sensitivity, less  capability 
of   coping with illness, inferior ability seek medical infor-
mation, and/or lower or uncertain expectations of  pain 
relief  and functional recovery.5,64,70,85,86,92 Edu cation about 
expectations, continued activity, and access to resources 
should be considered not only for those opting for THR, 
but also for those choosing non-surgical treatment for 
OA as  education in these areas may serve as preventative 
measures against the development of  depressive symp-
toms as well, which are common in this population.100 
Indications for THR
There is a lack of  consensus about indications for THR 
and inconsistencies across nations in the timing of  treat-
ment with this procedure. THR is provided to a young-
er population in the United States than in Europe for 
 example, and Gromov et al found that American pa-
tients also had less severe OA than those in Europe.36 
The ultimate goal of  works like those summarized here 
is to identify as many risk factors for poor PRO as pos-
sible. Identified risk factors can then be implemented 
into regional and/or global universal standards for ideal 
THR indications. Development of  a decision-making 
tool for referring clinicians and orthopaedic surgeons 
will not only standardize indications, but possibly identi-
fy the ideal interval at which patients will see the greatest 
improvement in their outcomes from THR. 
At the national level, optimization of  indication and timing 
may minimize clinically unnecessary follow-up appoint-
ments and possibly revision, thereby improving the cost 
utility of  treatment of  OA with THR and identifying ideal 
treatment paths for patients with this common condition. 
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A patient’s musculoskeletal comorbidities, socioeco-
nomic status, and mental health are all important de-
mographic elements to understand when considering 
treatment of  hip OA with THR. These factors will in-
fluence how a patient will report their HRQoL, pain, 
and satisfaction one year after surgery. Gender and age 
also play a role in predicting these outcomes, but marital 
status seems to have little influence. 
The EQ-5D survey is a brief  measure of  HRQoL mak-
ing it appealing for large-scale studies. The  newer ver-
sion of  this survey with five answer options appears to 
provide a better measure of  HRQoL both before and 
after treatment with THR. While a weighted index for 
this version of  the  survey does not yet exist, the rela-
tionship between the preoperative score and the post-
operative score will be as important to understand as in 
the three-level version of  the survey. A two-line model 
with a single change point was ideal for describing the 
relationship between the pre- and postoperative scores 
in the three-level version of  the EQ-5D index in the 
Swedish population. Prior to implementation, it will be 
important to establish if  this holds true for the five­level 
version and for other populations. In Sweden, a two-line 
Conclusions
model with a single change point should be implement-
ed when modeling the influence of  additional patient 
factors on patient-reported HRQoL as measured by the 
EQ-5D-3L survey.
Because surgeons need to synthesize so many patient 
characteristics when deciding to recommend THR, an 
evidence based decision-making tool could streamline 
this process. Several characteristics proved valuable 
when estimating the probability that a patient would 
be recommended for THR surgery and whether they 
would proceed. In the arthroplasty clinic at MGH, the 
most critical was the space remaining in the joint as mea-
sured on an AP radiograph. Patient-reported assessment 
of  the individual’s health and hip condition were also 
important for both predictions, indicating that PROMs 
would be a valuable addition to a decision tool. Imple-
mentation of  the developed probability prediction tool 
in the MGH arthroplasty clinic will ultimately determine 
if  the tool might help aid the decision-making process 
for both clinicians and patients thereby improving treat-
ment by streamlining patient assessment, selection, and 
recommendations.
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Decision-making Tool
Together these works provide information regarding 
 patient characteristics that will indicate the need for 
THR, how to measure changes in the patient’s con-
dition after THR, and identify those who may be at a 
higher risk for poor outcomes after THR. Ideally, we 
will be able to make a tool with the capability of  syn-
thesizing these factors as a means to identify ideal THR 
candidates. The goal of  this decision tool is three fold. 
It will identify the patients who have the greatest need 
for treatment with THR. It will help clinicians target 
patients who have the greatest capacity to improve af-
ter THR, which will in turn improve the effectiveness 
of  this widely used treatment. Finally, more targeted 
recommendations for THR can ultimately improve the 
cost utility of  the procedure by minimizing unnecessary 
healthcare utilization. It will be important to conduct 
either cohort studies or randomized trials to identify 
favorable alterative treatment options for those individ-
uals who may not benefit from THR. In a collabora-
tive effort between the SHAR and Harris Orthopaedic 
Laboratory, we aim to create this easy to use tool that 
will aid shared decision-making between the patient 
and either primary care or arthroplasty clinicians about 
whether to proceed with THR.
Outcomes at MGH
The new PROM protocol at MGH remains active, and 
therefore, data collection continues with postoperative 
collection of  PROMs from the individuals included in 
paper VI as well as enrollment of  any new patients at 
Ongoing Projects
the clinic. Utilizing the same demographic, radiographic, 
and preoperative patient-reported data, a similar investi-
gation as outlined in paper VI will be used to determine 
which patient factors are associated with PROs 1 year 
postoperatively and eventually at 3, 5, 7, and 10 years. 
The addition of  outcome data to the prediction algo-
rithm will not only provide an indication of  who will 
be recommended for THR, but also will indicate the 
probability of  improvement, no change, or degradation 
after treatment. After this analysis we will have a better 
understanding of  which PROMs are helpful in predict-
ing THR recommendations as well as outcomes after 
surgery and will then be able to hone the PROM proto-
col to minimize the burden on the patient.
Since completion of  paper VI, I have been in contact 
with another group investigating how to improve deci-
sion-making in the arthroplasty clinic at MGH. Because 
education data in the charts is spotty, this group has 
been collecting education data directly from the patients. 
Through collaboration with this group, I can incorpo-
rate this important measure of  socioeconomic status 
into our models. Inclusion of  education may identify if  
socioeconomic status influences a patient’s decision to 
have THR and whether it is associated with their out-
comes in this US population. 
Implementation of EQ-5D-5L
A similar protocol as that implemented in paper V will 
be utilized at centers in the western region of  Sweden 
asking preoperative and postoperative patients to com-
plete both versions of  the EQ-5D survey. Ethical com-
mittee approval was obtained and patient recruitment 
will continue until Spring of  2016. The goal of  the in-
vestigation is the same of  that in paper V, to validate 
the new EQ-5D-5L survey this time in a Swedish popu-
lation. 
Considerations are currently being made as to when the 
arthroplasty clinic at MGH will change their standard 
PROM protocol to include the five­level version of  the 
EQ-5D survey in place of  the three-level version. The 
absence of  a validated index for the five­level version 
makes it necessary for the clinicians to agree to use 
the crosswalk from the three-level survey index to the 
five­level version.
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Streamlining Questionnaire Burden
Successful patient-reported data collection is depen-
dent upon straightforward survey administration with 
minimal burden on the patient or clinical office. The 
National Institutes of  Health (NIH) have developed 
the Patient-reported Outcome Measurement Infor-
mation System (PROMIS) as a means to standardize 
 patient-reported assessment in clinical studies funded 
by the NIH. Some of  the PROMIS measures employ 
computer adaptive testing (CAT) as a means to stream-
line the burden on the patient. CAT instruments provide 
the user with a bank of  questions of  which only a few 
are administered. The system draws from the pool of  
items based on the response to the pre vious item. CAT 
 systems require a substantial initial effort to identify the 
ideal questions for the item bank through item response 
theory. Once established however, a CAT system can 
provide a survey that requires the patient to answer very 
few questions by eliminating items that do not apply 
to the respondent. Implementation of  CAT systems 
in national arthro plasty registers is a theoretically desir-
able way to expand the use of  PRO within additional 
national registers because the burden on the patient is 
minimized. However, several administrative challenges 
remain both for registers currently using PROMs and 
those who are not. Funding would be needed to con-
duct the initial validation studies for the CAT system or 
to pay for the use of  an established  system, dedicated 
staff  for data management and analy sis would still be re-
quired, and comparisons to previously collected PROM 
data may become problematic. Organizations such a the 
International Society of  Arthroplasty Registers or the 
American Academy of  Orthopaedic Surgeons could 
perhaps facilitate development of  a PRO CAT system, 
but then language and cultural differences would need 
to be accounted for. Despite these challenges, a system 
for collecting standardized THR PROs that asks for 
minimal effort from the patient is desirable. 
Access to THR
An important problem being discussed particularly in 
the United States, but in other nations as well is access 
to healthcare. The severity of  OA symptoms can be 
corre lated with socioeconomic status, and those with 
low socioeconomic status have a greater unmet need 
Future Visions
for arthroplasty.16,38 Their willingness to receive this 
treatment is equal to that of  their peers indicating that 
patient inclination does not account for the discrepan-
cy.42 Individuals with lower socioeconomic status tend 
to have low-income jobs that are more labor intensive 
therefore increasing their chances for development of  
OA.16,53 The disparity between OA patients with low 
socio economic status and access to THR exists even in 
countries with seemingly equal access to healthcare.21,22,42 
It is important to understand how to provide access 
to THR for all who may benefit from this treatment, 
and although these individuals may be at risk for lower 
PROs, they still have marked improvements. The ability 
for these individuals to return or continue to work may 
even have a greater influence on HRQoL further down 
the line.
PROMs for Assessing Follow-up Needs
It has been discussed to use PROMs as a measure of  
whether a patient needs to be seen for a follow-up 
visit in the clinic. Materials development for THR has 
reached a plateau. While component manufacturers 
continue to develop new implant materials, a collection 
of  safe, very well performing components with excellent 
10-year in vivo track records already exist.31 If  new mate-
rials are used, regular follow-up should be encouraged to 
ensure their safety. If  well-established, vetted materials 
are used, follow-up in the clinic with radiographs may 
not be necessary for the majority of  patients. Any pa-
tient having problems or those who desire time with the 
clinician would still have that option, but because THR 
tends to be highly successful, many patients do not want 
to return for follow-up. With the increase in THRs ad-
ministered, the pool of  individuals requiring follow-up 
is increasing. Also with the increased longevity of  THR 
components, younger patients are receiving this treat-
ment. For some high volume surgeons, regular in-clinic 
follow-up is unmanageable for all patients. 
By asking the patient to complete a set of  surveys either 
on paper forms in the mail or through a web-based link 
sent through email as a precursor to an in-person clinic 
visit, PROMs can be used to screen patient needs. If  
an individual was having no problems and had favor-
able PROs, they might not be asked to come see the 
doctor. This system would provide the clinician with 
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information regarding the patient’s wellbeing with mini-
mal  effort. Whereas in the current system in the United 
States, if  a patient does not return for follow-up, the 
clinician may not know whether the patient was doing 
so well that they did not want to return for follow-up, 
or whether they were very unhappy or having problems 
and went to see a different doctor. 
The growing cost of  healthcare in the United States ne-
cessitates systematic changes in how care is provided. By 
eliminating unnecessary office visits and clinical radio­
graphs, the cost of  treatment with THR can be mini-
mized not to mention the burden on the patient. In this 
scenario, ideal PROMs would need to be identified and 
thresholds for those surveys would need to be estab-
lished to identify when a patient might benefit from a 
return visit to the clinic. 
Shared Decision-making
In order for shared decision-making to be successful, 
a large burden is placed on the healthcare profession-
al. Accurate tools to help guide the patient to the most 
beneficial decision with an acceptable level of  risk may 
exist, but the process of  engaging the patient in the de-
cision process takes skill, training, and willingness on 
the part of  the clinician. Consultation techniques for 
shared decision-making have been developed. Howev-
er, exploration of  such techniques is limited in ortho-
paedics.93  Additionally, many of  these programs were 
designed to reduce rates of  elective procedures and will 
likely increase the required time spent with the patient 
in the clinic.104 For these reasons among others, adop-
tion of   dedicated shared decision-making programs in 
arthro plasty has been slow. Because the historic meth-
od of  paternalistic consultation in arthroplasty conflicts 
with shared decision-making philosophies, bridging 
this  divide becomes important. Orthopaedic surgeons 
are known for early adoption of  new technologies and 
therefore, are likely to adopt a new electronic tool for 
decision-making rather than learn specialized techniques 
for patient engagement. How best to instigate partici-
pation in shared decision-making processes by ortho-
paedic surgeons needs to be explored.
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Summary in English
This collection of  works aimed to identify patient factors 
that could help predict how a patient would self-report 
their health-related quality of  life, pain, and satisfaction 
with the outcomes from surgery one year after total hip 
replacement. Among the investigated variables were age, 
gender, Charnley classification, education level, marital 
status, antidepressant use, and the presence of  comor-
bid conditions. Through these studies, the works also 
aimed to identify ideal methodologies for considering 
patient­reported outcomes and the influence of  patient 
factors on them. 
Linear regression was utilized in most studies to iden-
tify the predictive capacity of  the aforementioned pa-
tient factors on the patient-reported outcomes at one 
year after total hip replacement. A new version of  one 
of  the patient-reported outcome measures, the EQ-5D, 
was investigated and found to have an improved abili-
ty to measure health-related quality of  life in total hip 
replacement patients both before and after treatment. 
 Finally, several patient-reported measures, demograph-
ics, and radiographic assessments were synthesized us-
ing a complex algorithm to identify the probability that a 
patient would be recommended for surgery and whether 
they would move forward with the treatment. 
Overall, patients improved after total hip replace-
ment. Those who started with worse patient-reported 
health-related quality of  life and pain tended to improve 
similar amounts as those going into surgery with better 
scores; however, they never achieved absolute scores 
that were as high. Individuals with greater musculoskel-
etal comorbidities, taking antidepressants, with low or 
 medium levels of  education tended to begin and end 
with worse patient-reported scores. 
Because these patients can be easily identified through 
preoperative surveys and their medical record, clinicians 
can quickly identify patients with whom they should 
more thoroughly discuss the risks for lower postopera-
tive scores after total hip replacement. While these find-
ings indicate who may benefit the most from total hip 
replacement, they are not intended to discourage treat-
ment, but rather provide the clinician and the patient 
with more information for the decision-making process 
with respect to treatment of  their hip condition.
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Målsättningen med det här avhandlingsarbetet var att 
identifiera patientrelaterade omständigheter och förhål-
landen som kan hjälpa till att förutsäga hur en patient 
kommer att uppleva sin hälsorelaterade livskvalitet, 
smärta och tillfredsställelse med resultatet av kirurgin ett 
år efter en höftprotesoperation. De undersökta variab-
lerna var ålder, kön, utbildningsgrad, civilstatus, medici-
nering med antidepressiva läkemedel, förekomsten av 
andra sjukdomar och huruvida patienten har besvär 
med gångförmågan på grund av annan sjuklighet än 
höftledssjukdom. Genom de här undersökningarna syf-
tade avhandlingsarbetet också till att identifiera lämpliga 
 metoder för att bedöma patientrapporterat utfall och 
hur patientfaktorer påverkar utfallet. 
Linjär regression användes i de flesta studierna för att 
förstå sambandet mellan de ovan nämnda patientfak-
torerna och det patientrapporterade utfallet ett år efter 
höftprotesoperation. En ny version av frågeformuläret 
EQ-5D undersöktes och visade sig ha bättre förmåga 
att mäta hälsorelaterad livskvalitet hos höftprotesope-
rerade patienter både före och efter operationen. I det 
sista delarbetet användes en rad patientrapporterade 
mått jämte demografiska variabler och artrosgrad mätt 
på röntgenbilder för att skapa en algoritm som räknar ut 
Summary in Swedish
en sannolikhet för att en patient skulle rekommenderas 
att genomgå höftprotesoperation och i så fall om patien-
ten skulle välja att gå vidare med åtgärden. 
På det hela taget förbättrades patienterna efter höft protes-
operation. De som hade sämre hälsorelaterad livskvalitet 
och högre smärta före operationen tenderade att förbätt-
ras lika mycket som de som hade bättre utgångsvärden. 
De med lägre utgångsvärden förbättrades emellertid inte 
till samma nivå som de med högre. Individer med andra 
sjukdomar som påverkar gångförmågan, de som använ-
der antidepressiva läkemedel samt låg- eller medelutbil-
dade tenderade att ha sämre värden på de patientrappor-
terade utfallsmåtten såväl före som efter operationen. 
Eftersom dessa patienter enkelt kan urskiljas med hjälp 
av frågeformulär, sjukhistoria och patientens journal kan 
läkaren snabbt identifiera dem som kan vara i behov av 
mer utförlig diskussion om risken att inte förbättras el-
ler bli missnöjd med resultatet. Även om dessa resultat 
kan indikera vem som kan ha störst nytta av en höft-
protesoperation är inte avsikten att avskräcka någon 
från operation utan istället ge läkaren och patienten mer 
information som underlag till det gemensamma beslutet 
om lämplig behandling av höftledssjukdomen.
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